Document:

ex10_1.htm

Exhibit 10.1

 

SECURITIES PURCHASE AGREEMENT

 

This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of January 7, 2011, among U.S. China Mining Group, Inc., a Nevada corporation (the “Company”), the investors listed on the Schedule of Investors attached hereto as Exhibit A and identified on the signature pages hereto (each, an “Investor” and collectively, the “Investors”) and, with respect to certain sections hereof, Euro Pacific Capital, Inc. (the “Placement Agent”).

 

WHEREAS, this Agreement has been entered into pursuant to the terms of the Company’s Confidential Private Placement Memorandum, dated December 16, 2010 (together with any and all amendments and/or supplements thereto, the “Memorandum”);

 

WHEREAS, subject to the terms and conditions set forth in this Agreement and in reliance upon the applicable exemptions from securities registration under the Securities Act (as defined below), the Company desires to issue and sell to each Investor, and each Investor, severally and not jointly, desires to purchase from the Company certain securities of the Company, as more fully described in this Agreement.

 

NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and the Investors agree as follows:

 

ARTICLE 1.

DEFINITIONS

 

1.1.           Definitions.  In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms shall have the meanings indicated in this Section 1.1:

 

“2010 Annual Report” means the Annual Report of the Company for the fiscal year ending December 31, 2010, as filed with the Commission on Form 10-K (or such other form appropriate for such purpose as promulgated by the Commission).

 

“2011 Annual Report” means the Annual Report of the Company for the fiscal year ending December 31, 2011, as filed with the Commission on Form 10-K (or such other form appropriate for such purpose as promulgated by the Commission).

 

“Action” as to any Person, means any action, suit, inquiry, notice of violation, proceeding (including any partial proceeding such as a deposition) or investigation pending or threatened in writing against or affecting such Person, any of such Person’s Subsidiaries or any of such Person’s or such Subsidiary’s respective properties, before or by any Governmental Body, arbitrator, regulatory authority (federal, state, county, local or foreign), stock market, stock exchange or trading facility.

 

  

  

  

 

“Affiliate” means, with respect to any specified Person:  (i) if such Person is an individual, the spouse of that Person and, if deceased or disabled, his heirs, executors, or legal representatives, if applicable, or any trusts for the benefit of such individual or such individual’s spouse and/or lineal descendants, or (ii) otherwise, another Person that directly, or indirectly through one or more intermediaries, controls, is controlled by, or is under common control with, the Person specified.  As used in this definition, “control” shall mean the possession, directly or indirectly, of the power to cause the direction of the management and policies of a Person, whether through the ownership of voting securities or by contract or other written instrument.

 

“Business Day” means any day except Saturday, Sunday and any day which is a federal legal holiday or a day on which banking institutions in the State of New York or Harbin, China are authorized or required by law or other governmental action to close.

 

“Closing Escrow Agreement” means the Closing Escrow Agreement, dated as of the date hereof, among the Company, the Placement Agent and the Escrow Agent identified therein, in the form of Exhibit C hereto, as may be amended from time to time.

 

“Commission” means the Securities and Exchange Commission.

 

“Common Stock” means the common stock of the Company, par value $0.001 per share, and any securities into which such common stock may hereafter be reclassified or for which it may be exchanged as a class.

 

“Common Stock Equivalents” means any securities of the Company or any Subsidiary which entitle the holder thereof to acquire Common Stock at any time, including without limitation, any debt, preferred stock, rights, options, warrants or other instrument that is at any time convertible into or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock or other securities that entitle the holder to receive, directly or indirectly, Common Stock.

 

“Company PRC Counsel” means AllBright Law Offices.

 

“Company U.S. Counsel” means McKenna Long & Aldridge LLP.

 

“Escrow Account” means the escrow account established by the Escrow Agent pursuant to the Closing Escrow Agreement where funds representing the Investors’ aggregate Investment Amount shall be held pending the Closings.

 

“Escrow Agent” means Escrow, LLC.

 

“Effective Date” means the date that the Registration Statement required by Section 2(a) of the Registration Rights Agreement is first declared effective by the Commission.

 

“Exchange Act” means the Securities Exchange Act of 1934, as amended.

 

  

2

  

 

“GAAP” means U.S. generally accepted accounting principles.

 

“Governmental Body” shall mean any:  (a) nation, state, commonwealth, province, territory, county, municipality, district or other jurisdiction of any nature; (b) federal, state, local, municipal, foreign or other government; or (c) governmental or quasi-governmental authority of any nature (including any governmental or administrative division, department, agency, commission, instrumentality, official, organization, unit, body or entity) and any court or other tribunal.

 

“Investment Amount” means, with respect to each Investor, the Investment Amount indicated on such Investor’s signature page to this Agreement, which is also reflected on the Schedule of Investors attached hereto as Exhibit A.

 

“Intellectual Property” means the Company’s patents, patent applications, provisional patents, trademarks, service marks, trade names, trademark registrations, service mark registrations, copyrights, licenses, formulae, mask works, customer lists, internet domain names, know-how and other intellectual property, including trade secrets and other unpatented and/or unpatentable proprietary or confidential information, systems, procedures or registrations or applications relating to the same.

 

“Investor” means any person who purchases Units in the Offering pursuant to this Agreement.

 

“Legal Requirement” shall mean any federal state, local, municipal, foreign or other law, statute, constitution, principle of common law, resolution, ordinance, code, edict, decree, rule, regulation, ruling or requirement issued, enacted, adopted, promulgated, implemented or otherwise put into effect by or under the authority of any Governmental Body (or under the authority of any national securities exchange upon which the Common Stock is then listed or traded).  Reference to any Legal Requirement means such Legal Requirement as amended, modified, codified, replaced or reenacted, in whole or in part, and in effect from time to time, and reference to any section or other provision of any Legal Requirement means that provision of such Legal Requirement from time to time in effect and constituting the substantive amendment, modification, codification, replacement or reenactment of such section or other provision.

 

“Lien” means any interest in Property securing an obligation owed to a Person whether such interest is based on the common law, statute or contract, and including but not limited to a security interest arising from a mortgage, lien, title claim, assignment, encumbrance, adverse claim, contract of sale, pledge, conditional sale or trust receipt or a lease, consignment or bailment for security purposes.  The term “Lien” includes but is not limited to mechanics’, materialmen’s, warehousemen’s and carriers’ liens and other similar encumbrances.  For the purposes hereof, a Person shall be deemed to be the owner of Property which it has acquired or holds subject to a conditional sale agreement or other arrangement pursuant to which title to the Property has been retained by or vested in some other Person for security purposes.

 

  

3

  

 

“Make Good Escrow Agreement” means the Make Good Escrow Agreement, dated as of the date hereof, among the Company, the Make Good Pledgor, the Placement Agent, and the escrow agent (the “Make Good Escrow Agent”) identified therein, in the form of Exhibit D hereto.

 

“Make Good Pledgor” means Mr. Yue Guoqing, Chairman of the Board of Directors of the Company.

 

“Maximum Amount” means $15,000,000.

 

“Material Adverse Effect” means any of (i) a material and adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material and adverse effect on the results of operations, assets, properties, prospects, business or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii) a material and adverse impairment to the Company’s ability to perform on a timely basis its obligations under any Transaction Document.

 

“Minimum Amount” means Units equal to at least the amount of $8,000,000 are required to be sold at the First Closing within the time period set forth in the Memorandum.

 

“New York Courts” means the state and federal courts sitting in the City of New York, Borough of Manhattan.

 

“Offering” shall mean the offering and sale of the Units pursuant to this Agreement and the Memorandum.

 

“Outside Date” means March 31, 2011.

 

“OTCBB” shall mean the Over-the-Counter Bulletin Board system.

 

“Person” means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

“Placement Agent Warrants” means warrants to be issued to the Placement Agent to purchase a number of shares of Common Stock derived by dividing an amount equal to 10% of the total number of shares of Common Stock purchased by Investors in the Offering.

 

“Placement Agent Warrants Shares” means the shares of Common Stock issuable upon the exercise of the Placement Agent Warrants.

 

“Proceeds” means approximately $10,000,000 to $15,000,000 (the “Gross Proceeds”) of the Offering which, net of expenses, will be utilized by the Company for capital expenditures, acquisitions and general corporate purposes.

 

  

4

  

 

“PRC” means the People’s Republic of China or any provincial, city or other jurisdiction therein, but not including Taiwan, the Hong Kong Special Administrative Region and the Macau Special Administrative Region.

 

“Proceeding” means an action, claim, suit, investigation or proceeding (including, without limitation, an investigation or partial proceeding, such as a deposition), whether commenced or, to the knowledge of the Company, threatened.

 

“Property” means any interest in any kind of property or asset, whether real, personal or mixed, or tangible or intangible.

 

“Registration Rights Agreement” means the Registration Rights Agreement, dated as of the date hereof, among the Company, the Investors and the Investor Representative, in the form of Exhibit B hereto.

 

“Registration Statement” means a registration statement meeting the requirements set forth in the Registration Rights Agreement and covering the resale by the Investors of the Registrable Securities as defined in the Registration Rights Agreement.

 

“Rule 144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

 

“Securities” means the Units, the Shares, the Warrants, and the Placement Agent Warrants.

 

“Securities Act” means the Securities Act of 1933, as amended.

 

“Shares” means the Shares of Common Stock purchased pursuant to this Offering as a part of the Units, Make Good Shares, Warrant Shares, and the Placement Agent Warrants Shares.

 

“Short Sales” include, without limitation, all “short sales” as defined in Rule 200 promulgated under Regulation SHO under the Exchange Act and all types of direct and indirect stock pledges, forward sale contracts, options, puts, calls, swaps and similar arrangements (including on a total return basis), and sales and other transactions through non-US broker dealers or foreign regulated brokers.

 

“Subsidiary” means any “significant subsidiary” as defined in Rule 1-02(w) of the Regulation S-X promulgated by the Commission under the Exchange Act.

 

“Trading Day” means:  (i) a day on which the Common Stock is traded on a Trading Market (other than OTCBB), or (ii) if the Common Stock is not listed on a Trading Market (other than OTCBB), a day on which the Common Stock is traded in the over the counter market, as reported by OTCBB, or (iii) if the Common Stock is not quoted on any Trading Market, a day on which the Common Stock is quoted in the over the counter market as reported by the Pink Sheets LLC (or any similar organization or agency succeeding to its functions of reporting prices); provided, that in the event that the Common Stock is not listed or quoted as set forth in (i), (ii) and (iii) hereof, then Trading Day shall mean a Business Day.

 

  

5

  

 

“Trading Market” means any of the New York Stock Exchange, the NYSE AMEX, the NASDAQ Global Select Market, the NASDAQ Global Market, the NASDAQ Capital Market (each of the foregoing shall also be a “National Exchange”), the OTCBB or any other market on which the Common Stock is listed or quoted for trading on the date in question.

 

“Transaction Documents” means this Agreement, the Memorandum, the Registration Rights Agreement, the Closing Escrow Agreement, the Make Good Escrow Agreement, the Warrants and the Placement Agent Warrants and any other documents or agreements executed in connection with the transactions contemplated hereunder.

 

“Transfer” shall mean any sale, transfer, assignment, conveyance, charge, pledge, mortgage, encumbrance, hypothecation, security interest or other disposition, or to make or effect any of the above.

 

“Transfer Agent” means Interwest Transfer Company, Inc., the current transfer agent of the Company with a mailing address 1981 Murray Holladay Road, Suite 100, Salt Lake City, UT  84117 and a facsimile number of (801) 277-3147, and any successor transfer agent of the Company.

 

“Unit” means a unit composed of one Share of Common Stock and one Warrant.

 

“U.S. Investor” means an Investor who is resident in the United States of America.

 

“Warrants” means the Common Stock purchase warrants, in the form of Exhibit E, issuable to each Investor at a Closing for the purchase of 0.5 of a Share of Common Stock at an exercise price of $6.80 per share, multiplied by the number of Units purchased by such Investor.

 

“Warrant Shares” means the shares of Common Stock issuable upon the exercise of the Warrants.

 

ARTICLE 2.

PURCHASE AND SALE

 

2.1.           Subscription for Units by the Investors.  Subject to the terms and conditions of this Agreement, on the Closing Date (as defined below), each of the Investors shall severally, and not jointly, purchase, and the Company shall sell and issue to each Investor, Units at a purchase price of $4.00 per Unit.

 

  

6

  

 

2.2.           Closing.

 

(a)           First Closing.  Subject to the terms and conditions set forth in this Agreement, the Company shall issue and sell to each Investor, and each such Investor shall, severally and not jointly, purchase from the Company on or before March 31, 2011, such number of Units set forth on the respective signature pages attached hereto, which will be reflected opposite such Investor’s name on Exhibit A (the “First Closing”).  Units equal to at least the Minimum Amount are required to be sold at the First Closing within the time period set forth in the Memorandum.

 

(b)           Subsequent Closing(s).  In the event that the Maximum Amount is not raised at the First Closing, the Company and the Placement Agent may mutually agree to have one or more subsequent Closings of the Offering (each, a “Subsequent Closing”) until the first to occur of:  (i) the Maximum Amount being raised and (ii) the Outside Date occurs.  At each Subsequent Closing, the Company agrees to issue and sell to each Investor who executes a signature page hereto, and each such Investor agrees, severally and not jointly, to purchase from the Company such number of Units set forth on such Investor’s signature pages attached hereto.  There may be more than one Subsequent Closing; provided, however, that the final Subsequent Closing shall take place on or before the Outside Date.  The date of any Subsequent Closing is hereinafter referred to as a “Subsequent Closing Date”).

 

(c)           Closing.  The First Closing and any applicable Subsequent Closings are each referred to in this Agreement as a “Closing.”  The First Closing Date and any Subsequent Closing Date are sometimes referred to herein as a “Closing Date.”  The Closing at which the Maximum Amount is raised, or which is the last Closing prior to the Outside Date, is referred to as the “Final Closing.”  The date of the Final Closing is referred to as the “Final Closing Date.”  All Closings shall occur on or prior to the Outside Date at the offices of Pillsbury Winthrop Shaw Pittman, LLP, 2300 N Street, N.W., Washington, D.C. 20037, as counsel for the Placement Agent, or remotely via the exchange of documents and signatures.

 

2.3.           Closing Deliveries.

 

(a)           At each Closing, the Company shall deliver or cause to be delivered to each Investor the following (the “Company Deliverables”):

 

(i)             a certificate for Shares;

 

(ii)            a Warrant;

 

(iii)           a certificate executed on behalf of the Company by its Chief Executive Officer or its Chief Financial Officer, dated as of the applicable Closing Date, certifying to the fulfillment of the conditions specified in Article 5 (the “Company Officer Certificate”);

 

  

7

  

 

(iv)           a certificate executed on behalf of the Company by its secretary dated as of the First Closing Date, certifying the resolutions adopted by the board of directors of the Company approving the transactions contemplated by this Agreement and the other Transaction Documents and the issuance of the Securities, certifying the current versions of the certificate of incorporation and bylaws of the Company and certifying as to the signatures and authority of persons signing the Transaction Documents and related documents on behalf of the Company (the “Company Secretary Certificate”).  The foregoing certificate shall only be required to be delivered on the First Closing Date, unless any material information contained in the certificate has changed.

 

(v)           the legal opinion of Company U.S. Counsel, in agreed form, addressed to the Investors and the Placement Agent.

 

(vi)           the legal opinion of Company PRC Counsel, in agreed form, addressed to the Investors and the Placement Agent.

 

(vii)          Lock Up Agreements.  The Company’s officers and directors shall have delivered to the Placement Agent a customary “lock-up” agreement in favor of the Placement Agent with respect to the securities of the Company owned by them, which agreement shall have a term of one year from the First Closing.

 

(b)           At each Closing, the Company shall deliver or cause to be delivered to the Placement Agent Placement Agent Warrants to purchase a number of shares of Common Stock equal to 10% of the total number of Units purchased by Investors at such Closing.

 

(c)            By the Closing, each Investor shall deliver or cause to be delivered the agreements specified in Article 5.2(d), each duly signed by such Investor (collectively, the “Investor Deliverables”).

 

(d)           At each Closing, the Company shall deliver to the Investors purchasing Units at such Closing, against delivery by the Investor of its Investment Amount, the Shares and Warrants.  At each Closing, each Investor shall deliver or cause to be delivered to the Escrow Agent, its Investment Amount, in United States dollars and in immediately available funds, by wire transfer to the account designated in writing by the Company for such purpose in accordance with the terms of the Closing Escrow Agreement.

 

2.4.           The Warrants.  The Warrants shall have the terms and conditions and be in the form attached hereto as Exhibit E.

 

2.5.           The Registration Rights Agreement.  The Registration Rights Agreement shall contain the terms and conditions and be in the form attached hereto as Exhibit C.

 

  

8

  

 

2.6.           Investor Representative.  Each Investor, severally and not jointly, hereby appoints the Placement Agent (together with its permitted successors, and in this context, the “Investor Representative”), as its true and lawful agent and attorney-in-fact without the need for any further consent or further action on the part of any Investor to:  (a) enter into any agreement in connection with the transactions contemplated by this Agreement and any transactions contemplated by the Transaction Documents, (b) accept delivery of the Shares and the Warrants comprising the Units purchased hereunder; (c) exercise all or any of the powers, authority and discretion conferred on such Investor under this Agreement or any of the Transaction Documents, (d) waive any terms and conditions of this Agreement or any of the Transaction Documents, including, but not limited to, waive any negative or affirmative covenants of the Company contained in any Transaction Document, (e) give and receive notices on such Investor’s behalf and to be such Investor’s exclusive representative with respect to any matter, suit, claim, action or proceeding arising with respect to any transaction contemplated by this Agreement or any Transaction Document, and the Investor Representative agrees to act as, and to undertake the duties and responsibilities of, such agent and attorney-in-fact.  This power of attorney is coupled with an interest and irrevocable.  The Investor Representative shall not be liable for any action taken or not taken by it in connection with its obligations under this Agreement:  (i) with the consent of Investors who, as of the date of this Agreement have subscribed for (or, if a Closing has occurred, as of the date of the latest Closing own) more than fifty percent (50%) of the Units; or (ii) in the absence of its own gross negligence or willful misconduct.  If the Investor Representative shall be unable or unwilling to serve in such capacity, its successor shall be named by those persons holding more than fifty percent (50%) of the Units who shall serve and exercise the powers of Investor Representative hereunder.

 

ARTICLE 3.

REPRESENTATIONS AND WARRANTIES

 

3.1.           Representations and Warranties of the Company.  Except as set forth in:  (i) the SEC Reports, (ii) the Memorandum, or (iii) the corresponding section of the Disclosure Schedules delivered to the Investor Representative concurrently herewith, the Company hereby makes the following representations and warranties as of the date hereof and as of the Closing Date to each Investor:

 

(a)           Subsidiaries.  A true and correct organizational chart of the Company and its Subsidiaries is included as Schedule 3.1(a).  Except as disclosed on Schedule 3.1(a), the Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, nonassessable and free of preemptive and similar rights to subscribe for or purchase securities.

 

(b)           There are no outstanding:  (i) securities of the Company or any Subsidiary convertible into or exchangeable for shares of capital stock or voting securities of any Subsidiary or (ii) options or other rights to acquire from the Company or any Subsidiary, or other obligation of the Company or any Subsidiary to issue, any capital stock, voting securities or securities convertible into or exchangeable for capital stock or voting securities of any Subsidiary (the items in clauses (i) and (ii) being referred to collectively as the “Subsidiary Securities”).  There are no outstanding obligations of the Company or any Subsidiary to repurchase, redeem or otherwise acquire any outstanding Subsidiary Securities.

 

  

9

  

 

(c)           Organization and Qualification.  The Company and each Subsidiary are duly incorporated or otherwise organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization (as applicable), with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted.  Neither the Company nor any Subsidiary is in violation of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational or charter documents.  Each of the Company and each Subsidiary is duly qualified to conduct its respective businesses and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect.

 

(d)           Authorization; Enforcement.  The Company has the requisite corporate and other power and authority to enter into and to consummate the transactions contemplated by each of the Transaction Documents and otherwise to carry out its obligations thereunder.  The execution and delivery of each of the Transaction Documents by the Company and the consummation by it of the transactions contemplated thereby have been duly authorized by all necessary action on the part of the Company, and no further action is required by the Company or any Subsidiary in connection therewith.  Each Transaction Document has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with its terms, will constitute the valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting generally the enforcement of, creditors’ rights and remedies or by other equitable principles of general application.

 

(e)           No Conflicts.  Except as set forth on Schedule 3.1(e), the execution, delivery and performance of the Transaction Documents by the Company and the consummation by the Company of the transactions contemplated thereby do not and will not (i) conflict with or violate any provision of the Company’s or any Subsidiary’s certificate or articles of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property or asset of the Company or a Subsidiary is bound or affected, or (iii) result in a violation of any Legal Requirement, order, judgment, injunction, decree or other restriction of any United States or PRC court or Governmental Body to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect.

 

  

10

  

 

(f)           Filings, Consents and Approvals.  Except as set forth on Schedule 3.1(f), neither the Company nor any Subsidiary is required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration with, any United States or PRC court or other federal, state, local or other Governmental Body or other Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than (i) the filing with the Commission of one or more Registration Statements in accordance with the requirements of the Registration Rights Agreement, (ii) filings required by state securities laws, (iii) the filing of a Notice of Sale of Securities on Form D with the Commission under Regulation D of the Securities Act, (iv) the filings required in accordance with Section 4.5 hereof, (v) those that have been made or obtained prior to the date of this Agreement, (vi) registrations, notices or filings required to be made in order to comply with the currency and exchange control requirements imposed by any Governmental Body or Legal Requirement in the PRC, if any, and (vii) other post closing securities filings or notifications required to be made under federal or state securities laws.

 

(g)           Issuance of the Securities.  The issuance of the Shares has been duly authorized and, when issued and paid for in accordance with the Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens.  The Warrants and Placement Agent Warrants have been duly and validly authorized and upon the due exercise of the Warrants and Placement Agent Warrants, the Warrant Shares and Placement Agent Warrant Shares will be duly and validly issued, fully paid and non-assessable free and clear of all Liens.  The Company has reserved from its duly authorized capital stock the maximum number of shares of Common Stock issuable pursuant to this Agreement, the Warrants and the Placement Agent Warrants.  The Make Good Shares have been duly authorized and, when transferred in accordance with the Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens.

 

(h)           Capitalization.

 

(i)            Schedule 3.1(h) sets forth as of the date hereof and as of the First Closing Date (a) the authorized capital stock of the Company; (b) the number and class of shares of capital stock issued and outstanding; (c) the number and class of shares of capital stock issuable pursuant to the Company’s stock incentive plans or agreements; and (d) the number and class of shares of capital stock issuable and reserved for issuance pursuant to securities exercisable for, or convertible into or exchangeable for any shares of capital stock of the Company and a description of the number and rights of such securities.

 

(ii)           Except as described on Schedule 3.1(h), all of the issued and outstanding shares of the Company’s capital stock issued have been duly authorized and validly issued and are fully paid, nonassessable and free of pre-emptive rights and were issued in full compliance with applicable state and federal securities law and any rights of third parties.

 

  

11

  

 

(iii)           Except as described on Schedule 3.1(h), no Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated by the Transaction Documents.

 

(iv)           Except as described on Schedule 3.1(h), there are no outstanding (i) shares of capital stock or voting securities of the Company or (ii) options, warrants, script rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exchangeable for, or giving any Person any right to subscribe for or acquire, any shares of capital stock or voting securities or securities convertible into or exchangeable for capital stock or voting securities of the Company, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue additional shares of capital stock or voting securities of the Company, or securities or rights convertible or exchangeable into shares of capital stock or voting securities of the Company (the items in clauses (i) and (ii) being referred to collectively as the “Company Securities”).  Except as described on Schedule 3.1(h), there are no outstanding obligations of the Company or any Subsidiary to repurchase, redeem or otherwise acquire any Company Securities.

 

(v)           Except as described on Schedule 3.1(h), the issuance and sale of the Securities will not obligate the Company to issue shares of Common Stock or other securities to any Person (other than the Investors) and will not result in a right of any holder of Company securities to adjust the exercise, conversion, exchange or reset price under such securities.

 

(vi)           Except as described on Schedule 3.1(h), there are no voting agreements, buy-sell agreements, option or right of first purchase agreements or other agreements of any kind among the Company and any of the securities-holders of the Company relating to the securities of the Company held by them.

 

(vii)          Except as described on Schedule 3.1(h), no Person has the right to require the Company to register any securities of the Company under the Securities Act, whether on a demand basis or in connection with the registration of securities of the Company for its own account or for the account of any other Person.

 

(i)           SEC Reports; Financial Statements.  The Company has filed all reports and registration statements required to be filed by it under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the twelve months preceding the date hereof (or such shorter period as the Company was required by law to file such reports) (the foregoing materials being collectively referred to herein as the “SEC Reports” and, together with the Memorandum and the Schedules to this Agreement (if any), the “Disclosure Materials”) on a timely basis or has timely filed a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension.  As of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act and the rules and regulations of the Commission promulgated thereunder, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading.  The financial statements of the Company and each Subsidiary included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing.  Such financial statements have been prepared in accordance with GAAP, and fairly present in all material respects the financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.

 

  

12

  

 

(j)           Press Releases.  The press releases (other than the industry data, research opinion or viewpoints contained therein that are derived from third party sources) disseminated by the Company during the twelve months preceding the date of this Agreement, either individually or taken as a whole, do not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made and when made, not misleading.  To the best knowledge of the Company, the industry data, research opinion or viewpoints derived from third party sources contained in the press releases disseminated by the Company during the twelve months preceding the date of this Agreement, are derived from valid and reputable sources without the need for consent and, either individually or taken as a whole, do not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made and when made, not misleading.

 

(k)           Material Changes.  Except as described on Schedule 3.1(k) or in the SEC Reports, since the date of the latest audited financial statements included within the SEC Reports, the Company and its Subsidiaries have not:

 

(i)             suffered any Material Adverse Effect;

 

(ii)            suffered any damage, destruction or loss, whether or not covered by insurance, in an amount in excess of $500,000;

 

(iii)           granted or agreed to make any increase in the compensation payable or to become payable by the Company or any of its Subsidiaries to any officer or employee, except for normal raises for nonexecutive personnel made in the ordinary course of business that are usual and normal in amount;

 

(iv)           declared, set aside or paid any dividend or made any other distribution on or in respect of the shares of capital stock of the Company or any of its Subsidiaries, or declared or agreed to any direct or indirect redemption, retirement, purchase or other acquisition by the Company or any of its Subsidiaries of such shares;

 

(v)            issued any shares of capital stock of the Company or any of its Subsidiaries, or any warrants, rights or options thereof, or entered into any commitment relating to the shares of capital stock of the Company or any of its Subsidiaries;

 

  

13

  

 

(vi)           adopted or proposed the adoption of any change in the Company’s Certificate of Incorporation or Bylaws;

 

(vii)          made any change in the accounting methods or practices they follow, whether for general financial or tax purposes, or any change in depreciation or amortization policies or rates adopted therein, or any tax election;

 

(viii)        sold, leased, abandoned or otherwise disposed of any real property or any machinery, equipment or other operating property other than in the ordinary course of their business;

 

(ix)           sold, assigned, transferred, licensed or otherwise disposed of any of the Company’s Intellectual Property or interest thereunder or other intangible asset except in the ordinary course of their business;

 

(x)            been involved in any dispute involving any employee which would reasonably be expected to have a Material Adverse Effect;

 

(xi)           entered into, terminated or modified any employment, severance, termination or similar agreement or arrangement with, or granted any bonuses (or bonus opportunity) to, or otherwise increased the compensation of any executive officer;

 

(xii)          entered into any material commitment or transaction (including without limitation any borrowing or capital expenditure);

 

(xiii)         amended or modified, or waived any default under, any Material Contract;

 

(xiv)         to the knowledge of the Company, incurred any material liabilities, contingent or otherwise, either matured or unmatured (whether or not required to be reflected in financial statements in accordance with GAAP, and whether due or to become due), except for accounts payable or accrued salaries that have been incurred by the Company since the date of the latest audited financial statements included within the SEC Reports, in the ordinary course of its business and consistent with the Company’s past practices;

 

(xv)          permitted or allowed any of their material property or assets to be subjected to any Lien;

 

(xvi)         settled any claim, litigation or action, whether now pending or hereafter made or brought;

 

  

14

  

 

(xvii)        made any capital expenditure or commitment for additions to property, plant or equipment individually in excess of $500,000, or in the aggregate, in excess of $750,000;

 

(xviii)       paid, loaned or advanced any amount to, or sold, transferred or leased any properties or assets to, or entered into any agreement or arrangement with any of their Affiliates, officers, directors or stockholders or, to the Company’s knowledge, any Affiliate or associate of any of the foregoing;

 

(xix)          made any amendment to, or terminated any agreement that, if not so amended or terminated, would be material to the business, assets, liabilities, operations or financial performance of the Company or any of its Subsidiaries;

 

(xx)           compromised or settled any claims relating to taxes, any tax audit or other tax proceeding, or filed any amended tax returns;

 

(xxi)          merged or consolidated with any other Person, or acquired a material amount of assets of any other Person;

 

(xxii)         entered into any agreement in contemplation of the transactions specified herein other than this Agreement and the other Transaction Documents; or

 

(xxiii)        agreed to take any action described in this Section or which would reasonably be expected to otherwise constitute a breach of any of the representations or warranties contained in this Agreement or any other Transaction Documents.

 

(l)             No Undisclosed Material Liabilities.  There are no liabilities of the Company or any Subsidiary of any kind whatsoever, whether accrued, contingent, absolute, determined, determinable or otherwise, and there is no existing condition, situation or set of circumstances which could reasonably be expected to result in such a liability, other than:

 

(i)             liabilities provided for in the audited consolidated balance sheet of the Company and the Subsidiaries as of December 31, 2009 or disclosed in the notes thereto; and

 

(ii)            other undisclosed liabilities which, individually or in the aggregate, have not resulted in or could reasonably be expected to result in a Material Adverse Effect.

 

  

15

  

 

(m)           Litigation.  There is no Action which (i) adversely affects or challenges the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii) except as disclosed in the SEC Reports, could, if there were an unfavorable decision, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect.  Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any director or officer thereof (in his or her capacity as such), is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty, except as disclosed in the Disclosure Materials.  There has not been, and to the knowledge of the Company, there is not pending or contemplated any investigation by the Commission involving the Company or any current or former director or officer of the Company (in his or her capacity as such).  The Commission has not issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.

 

(n)           Labor Relations.  Neither the Company nor any Subsidiary is a party to or bound by any collective bargaining agreements or other agreements with labor organizations.  Neither the Company nor any Subsidiary has violated in any material respect any laws, regulations, orders or contract terms, affecting the collective bargaining rights of employees, labor organizations or any laws, regulations or orders affecting employment discrimination, equal opportunity employment, or employees’ health, safety, welfare, wages and hours.  No material labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company or any Subsidiary which could reasonably be expected to result in a Material Adverse Effect.

 

(o)           Compliance.  Neither the Company nor any Subsidiary (i) is in default under or in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default or violation has been waived), (ii) is in violation of any order of any court, arbitrator or Governmental Body, or (iii) is or has been in violation of any statute, rule or regulation of any governmental authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor matters, except in each case as could not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect.  The Company is in compliance with all effective requirements of the Sarbanes-Oxley Act of 2002, as amended, and the rules and regulations thereunder, that are applicable to it, except where such noncompliance could not have or reasonably be expected to result in a Material Adverse Effect.

 

(p)           Regulatory Permits.  The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports and the Memorandum, except where the failure to possess such permits could not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect (the “Material Permits”), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or modification of any Material Permit.

 

  

16

  

 

(q)           Title to Assets.  The Company and the Subsidiaries own, lease or otherwise have a valid right to use, all real property that is material to their respective businesses and good and marketable title in fee simple or the right to use under PRC law, as the case may be, to all personal property owned by them that is material to the business of the Company and the Subsidiaries, in each case free and clear of all Liens, except for Liens as do not materially affect the value of such property and do not materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and Liens for the payment of federal, state or other taxes, the payment of which is neither delinquent nor subject to penalties.  Any real property and facilities held under lease by the Company and the Subsidiaries are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance, except as could not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect.

 

(r)             Material Contracts.  Schedule 3.1(r) contains a listing and description of all material agreements, contracts or instruments, including all amendments thereto, to which the Company or its Subsidiaries are bound which have not been filed as exhibits to any SEC Reports.  The Company has made available to the Investors copies (either hard copies or via the SEC’s EDGAR system) of the Material Contracts (as defined below).  Except as described on Schedule 3.1(r) or the SEC Reports, neither the Company nor any of its Subsidiaries has entered into any oral contracts which, if written, would qualify as a Material Contract.  Each of the Material Contracts is valid and in full force and effect, is enforceable in accordance with its terms, subject to applicable bankruptcy, insolvency, reorganization, fraudulent transfer, moratorium or similar laws affecting creditors’ rights generally and general principles of equity, and will continue to be so immediately following the Closing Date.  Except for the agreements, contracts, instruments and other exhibits filed as part of the SEC Reports or described on Schedule 3.1(r) (such agreements, contracts or instruments, collectively, the “Material Contracts”), neither the Company nor any of its Subsidiaries is party or subject to, or bound by:

 

(i)             any agreements, contracts or commitments that call for prospective fixed and/or contingent payments or expenditures by or to the Company or any of its Subsidiaries of more than $500,000, or which is otherwise material and not entered into in the ordinary course of business;

 

(ii)            any contract, lease or agreement involving payments in excess of $500,000, which is not cancelable by the Company or any of its Subsidiaries, as applicable, without penalty on not less than 60 days notice;

 

(iii)           any contract, including any distribution agreements, containing covenants directly or explicitly limiting the freedom of the Company or any of its Subsidiaries to compete in any line of business or with any Person or to offer any of its products or services;

 

  

17

  

 

(iv)           any material indenture, mortgage, promissory note, loan agreement, guaranty or other agreement or commitment for the borrowing of money or pledging or granting a security interest in any assets;

 

(v)           any employment contracts, non-competition agreements, invention assignments, severance or other agreements with officers, directors, employees, stockholders or consultants of the Company or any of its Subsidiaries or Persons related to or affiliated with such Persons;

 

(vi)           any stock redemption or purchase agreements or other agreements affecting or relating to the capital stock of the Company or any of its Subsidiaries, including, without limitation, any agreement with any stockholder of the Company or any of its Subsidiaries which includes, without limitation, antidilution rights, voting arrangements or operating covenants;

 

(vii)         any pension, profit sharing, retirement, stock option or stock ownership plans;

 

(viii)        any royalty, dividend or similar arrangement based on the revenues or profits of the Company or any of its Subsidiaries or based on the revenues or profits derived from any material contract;

 

(ix)           any acquisition, merger, asset purchase or other similar agreement; or

 

(x)            any agreement under which the Company or any of its Subsidiaries has granted any Person registration rights for securities.

 

(s)           Actions with Respect to Material Contracts.

 

(i)            Neither the Company nor any of its Subsidiaries has violated or breached, or committed any default under, any Material Contract in any material respect, and, to the Company’s knowledge, no other Person has violated or breached, or committed any default under any Material Contract, except for violations, breaches of defaults which would not have a Material Adverse Effect; and

 

(ii)           To the Company’s knowledge, no event has occurred, and no circumstance or condition exists, that (with or without notice or lapse of time) will, or would reasonably be expected to:  (A) result in a material violation or breach of any of the provisions of any Material Contract, (B) give any Person the right to declare a default or exercise any remedy under any Material Contract, (C) give any Person the right to accelerate the maturity or performance of any Material Contract or (D) give any Person the right to cancel, terminate or modify any Material Contract, except, in each case, as would not have a Material Adverse Effect.

 

  

18

  

 

(t)            Taxes.

 

(i)            The Company and its Subsidiaries have timely and properly filed all tax returns required to be filed by them for all years and periods (and portions thereof) for which any such tax returns were due, except where the failure to so file would not have a Material Adverse Effect.  All such filed tax returns are accurate in all material respects.  The Company has timely paid all taxes due and payable (whether or not shown on filed tax returns), except where the failure to so pay would not have a Material Adverse Effect.  There are no pending assessments, asserted deficiencies or claims for additional taxes that have not been paid.  The reserves for taxes, if any, reflected in the SEC Reports or in the Memorandum are adequate, and there are no Liens for taxes on any property or assets of the Company and any of its Subsidiaries (other than Liens for taxes not yet due and payable).  There have been no audits or examinations of any tax returns by any Governmental Body, and the Company or its Subsidiaries have not received any notice that such audit or examination is pending or contemplated.  No claim has been made by any Governmental Body in a jurisdiction where the Company or any of its Subsidiaries does not file tax returns that it is or may be subject to taxation by that jurisdiction.  To the knowledge of the Company, no state of facts exists or has existed which would constitute grounds for the assessment of any penalty or any further tax liability beyond that shown on the respective tax returns.  There are no outstanding agreements or waivers extending the statutory period of limitation for the assessment or collection of any tax.  Neither the Company nor any of its Subsidiaries is a party to any tax-sharing agreement or similar arrangement with any other Person.

 

(ii)           The Company has made all necessary disclosures required by Treasury Regulation Section 1.6011-4.  The Company has not been a participant in a “reportable transaction” within the meaning of Treasury Regulation Section 1.6011-4(b).

 

(iii)           No payment or benefit paid or provided, or to be paid or provided, to current or former employees, directors or other service providers of the Company will fail to be deductible for federal income tax purposes under Section 280G of the Internal Revenue Code of 1986, as amended (the “Code”).

 

(u)           Employees.

 

(i)            The Company and its Subsidiaries are not party to any collective bargaining agreements and, to the Company’s knowledge, there are no attempts to organize the employees of the Company or any of its Subsidiaries.

 

(ii)            Except as set forth in the SEC Reports, the Company and its Subsidiaries have no policy, practice, plan or program of paying severance pay or any form of severance compensation in connection with the termination of employment services.

 

(iii)           Each Person who performs services for the Company or any of its Subsidiaries has been, and is, properly classified by the Company or its Subsidiaries as an employee or an independent contractor (or its PRC equivalent).

 

  

19

  

 

(iv)           To the Company’s knowledge, no employee or advisor of the Company or any of its Subsidiaries is or is alleged to be in violation of any term of any employment contract, disclosure agreement, proprietary information and inventions agreement or any other contract or agreement or any restrictive covenant or any other common law obligation to a former employer relating to the right of any such employee to be employed by the Company or any of its Subsidiaries because of the nature of the business conducted or to be conducted by the Company or any of its Subsidiaries or to the use of trade secrets or proprietary information of others, and the employment of the employees of the Company and its Subsidiaries does not subject the Company or the Company’s stockholders to any liability.  There are neither pending nor, to the Company’s knowledge, threatened any actions, suits, proceedings or claims, or, to the Company’s knowledge, any basis therefor or threat thereof with respect to any contract, agreement, covenant or obligation referred to in the preceding sentence.

 

(v)           Intellectual Property.  The Company and the Subsidiaries have, or have rights to use, all U.S., PRC or other foreign patents, patent applications, trademarks, trademark applications, service marks, trade names, copyrights, licenses and other similar rights (collectively, the “Intellectual Property Rights”) that are necessary or material for use in connection with their respective businesses as described in the SEC Reports and the Memorandum and which the failure to so have could, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect.  Neither the Company nor any Subsidiary has received a written notice that the Intellectual Property Rights used by the Company or any Subsidiary violates or infringes upon the rights of any Person.  Except as set forth in the SEC Reports, to the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual Property Rights.  The Company and its Subsidiaries have taken reasonable steps to protect the Company’s and its Subsidiaries’ rights in their Intellectual Property Rights and confidential information (the “Confidential Information”).  Each employee, consultant and contractor who has had access to Confidential Information which is necessary for the conduct of Company’s and each of its Subsidiaries’ respective businesses as currently conducted or as currently proposed to be conducted has executed an agreement to maintain the confidentiality of such Confidential Information and has executed appropriate agreements that are substantially consistent with the Company’s standard forms thereof.  Except under confidentiality obligations, there has been no material disclosure of any of the Company’s or its Subsidiaries’ Confidential Information to any third party.

 

(w)           Environmental Matters.  Except as described in Schedule 3.1(w), neither the Company nor any Subsidiary:  (i) is in violation of any statute, rule, regulation, decision or order of any Governmental Body relating to the use, disposal or release of hazardous or toxic substances or relating to the protection or restoration of the environment or human exposure to hazardous or toxic substances (collectively, “Environmental Laws”), (ii) owns, leases, has rights in the PRC to or operates any real property contaminated with any substance that is subject to any Environmental Laws, (iii) is liable for any off-site disposal or contamination pursuant to any Environmental Laws, or (iv) is subject to any claim relating to any Environmental Laws, and there is no pending or, to the Company’s knowledge, threatened investigation that might lead to such a claim.

 

  

20

  

 

(x)            Certain Fees.  Except as described in Schedule 3.1(x), no brokerage or finder’s fees or commissions are or will be payable by the Company to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated by this Agreement.  The Investors shall have no obligation with respect to any fees or with respect to any claims (other than such fees or commissions owed by an Investor pursuant to written agreements executed by such Investor which fees or commissions shall be the sole responsibility of such Investor) made by or on behalf of other Persons for fees of a type contemplated in this Section that may be due in connection with the transactions contemplated by this Agreement.

 

(y)           Investment Company.  The Company is not, and is not an Affiliate of, and immediately following the Closing will not have become, an “investment company” within the meaning of the Investment Company Act of 1940, as amended.

 

(z)            No Additional Agreements.  The Company does not have any agreement or understanding with any Investor with respect to the transactions contemplated by the Transaction Documents other than as specified in the Transaction Documents.

 

(aa)          Consultation with Auditors.  The Company has consulted its independent auditors concerning the accounting treatment of the transactions contemplated by the Transaction Documents, and in connection therewith has furnished such auditors complete copies of the Transaction Documents.

 

(bb)         Foreign Corrupt Practices Act.  Neither the Company nor any Subsidiary, nor to the knowledge of the Company, any agent or other person acting on behalf of any of the Company or any Subsidiary, has, directly or indirectly, (i) used any funds, or will use any proceeds from the sale of the Securities, for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any Person acting on their behalf of which the Company is aware) which is in violation of any Legal Requirement, or (iv) has violated in any material respect any provision of the Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder.

 

(cc)          Exemption from Registration.  Subject to the accuracy of the Investors’ representations and warranties set forth in this Section 3, except as required pursuant to the Registration Rights Agreement, the sale of Securities by the Company to the Investors will not require registration under the Securities Act.  The Company is issuing Securities in accordance with and in reliance upon the exemption from securities registration afforded, inter alia, by Rule 506 under Regulation D or Rule 902 under Regulation S as promulgated by the Commission under the Securities Act.

 

  

21

  

 

(dd)          No Integrated Offering.  Other than in connection with this Offering, neither the Company, nor any of its affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any securities or solicited any offers to buy any securities, under circumstances that would cause this offering of the Securities to be integrated with prior offerings by the Company for purposes of the Securities Act which would require the registration of any such securities under the Securities Act or any applicable shareholder approval provisions, including, without limitation, under the rules and regulations of any exchange or automated quotation system on which any of the securities of the Company are listed or designated.

 

(ee)          Brokers and Finders.  Other than as described in the Memorandum, no Person will have, as a result of the transactions contemplated by the Transaction Documents, any valid right, interest or claim against or upon the Company, any Subsidiary or an Investor for any commission, fee or other compensation pursuant to any agreement, arrangement or understanding entered into by or on behalf of the Company.

 

(ff)           No Directed Selling Efforts or General Solicitation.  Neither the Company nor any Person acting on its behalf has conducted any general solicitation or general advertising (as those terms are used in Regulation D) in connection with the offer or sale of any of the Securities.

 

(gg)          Questionable Payments.  Neither the Company nor any of its Subsidiaries nor, to the Company’s knowledge, any of their respective current or former stockholders, directors, officers, employees, agents or other Persons acting on behalf of the Company or any Subsidiary, has on behalf of the Company or any Subsidiary or in connection with their respective businesses:  (a) used any corporate funds for unlawful contributions, gifts, entertainment or other unlawful expenses relating to political activity; (b) made any direct or indirect unlawful payments to any governmental officials or employees from corporate funds; (c) established or maintained any unlawful or unrecorded fund of corporate monies or other assets; (d) made any false or fictitious entries on the books and records of the Company or any Subsidiary; or (e) made any unlawful bribe, rebate, payoff, influence payment, kickback or other unlawful payment of any nature.

 

(hh)          Solvency.  The Company has not (a) made a general assignment for the benefit of creditors; (b) filed any voluntary petition in bankruptcy or suffered the filing of any involuntary petition by its creditors; (c) suffered the appointment of a receiver to take possession of all, or substantially all, of its assets; (d) suffered the attachment or other judicial seizure of all, or substantially all, of its assets; (e) admitted in writing its inability to pay its debts as they come due; or (f) made an offer of settlement, extension or composition to its creditors generally.

 

  

22

  

 

(ii)            Related Party Transactions.  Except as set forth in the SEC Reports or the Memorandum:  (a) none of the Company or any of its Affiliates, officers, directors, stockholders or employees, or any Affiliate of any of such Person, has any material interest in any property, real or personal, tangible or intangible, including the Company’s Intellectual Property used in or pertaining to the business of the Company, except for the normal rights of a stockholder, or, to the knowledge of the Company, any supplier, distributor or customer of the Company; (b) there are no agreements, understandings or proposed transactions between the Company and any of its officers, directors, employees, Affiliates, or, to the Company’s knowledge, any Affiliate thereof; (c) to the Company’s knowledge, no employee, officer or director of the Company or any of its Subsidiaries has any direct or indirect ownership interest in any firm or corporation with which the Company is affiliated or with which the Company has a business relationship, or any firm or corporation that competes with the Company; (d) to the Company’s knowledge, no member of the immediate family of any officer or director of the Company is directly or indirectly interested in any Material Contract; and (e) there are no amounts owed (cash and stock) to officers, directors and consultants (salary, bonuses or other forms of compensation).

 

(jj)            OFAC.  None of the Company or any of its Subsidiaries nor, to the knowledge of the Company, any director, officer, agent, employee, Affiliate or Person acting on behalf of the Company or any of its Subsidiaries, is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”); and the Company will not directly or indirectly use the proceeds of the sale of the Securities, or lend, contribute or otherwise make available such proceeds to any of the Company’s Subsidiaries, joint venture partner or other Person or entity, towards any sales or operations in Cuba, Iran, Syria, Sudan, Myanmar or any other country sanctioned by OFAC or for the purpose of financing the activities of any Person currently subject to any U.S. sanctions administered by OFAC.

 

(kk)          Money Laundering Laws.  The operations of each of the Company or any of its Subsidiaries are and have been conducted at all times in compliance with the money laundering statutes of applicable jurisdictions, the rules and regulations thereunder of all applicable Governmental Bodies of the PRC and any related or similar rules, regulations or guidelines, issued, administered or enforced by any Governmental Body (collectively, the “Money Laundering Laws”) and no action, suit or proceeding by or before any PRC court or PRC Governmental Body or any arbitrator involving the Company and/or any Subsidiary with respect to the Money Laundering Laws is pending or, to the best knowledge of the Company, threatened.

 

(ll)            Disclosure.  All disclosure provided to the Investors regarding the Company, the Subsidiaries or their respective businesses and the transactions contemplated hereby, furnished by or on behalf of the Company (including the Company’s representations and warranties set forth in this Agreement and the disclosure set forth in any diligence report or business plan provided by the Company or any Person acting on the Company’s behalf) are true and correct in all material aspects and do not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made therein, in light of the circumstances under which they were made, not misleading.

 

  

23

  

 

(mm)        Internal Accounting and Disclosure Controls.  Except as set forth in the SEC Reports, the Company maintains a system of internal accounting controls sufficient to provide reasonable assurance that (a) transactions are executed in accordance with management’s general or specific authorization, (b) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability, (c) access to assets is permitted only in accordance with management’s general or specific authorization and (d) the recorded accountability for assets is compared with the existing assets at quarterly intervals and appropriate action is taken with respect to any material differences.  The Company maintains disclosure controls and procedures (as such term is defined in Rule 13a-15 under the Exchange Act) that are effective in ensuring that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the rules and forms of the Commission, including, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the Company’s management, including its principal executive officer or officers and its principal financial officer or officers, as appropriate, to allow timely decisions regarding required disclosure.

 

(nn)         Off Balance Sheet Arrangements.  There is no transaction, arrangement, or other relationship between the Company and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in the SEC Reports and is not so disclosed.

 

(oo)         Sarbanes-Oxley Act of 2002.  The Company is in material compliance with all provisions of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”) that are applicable to it as of the date hereof and as of the Closing Date.  Other than as disclosed in the SEC Reports, there has been no change in the Company’s accounting policies since inception.  Other than as disclosed in the SEC Reports, each required form, report and document containing financial statements that has been filed with or submitted to the Commission since January 1, 2008 was accompanied by the certifications required to be filed or submitted by the Company’s chief executive officer and chief financial officer pursuant to the Sarbanes-Oxley Act, and at the time of filing or submission of each such certification, such certification was true and accurate and materially complied with the Sarbanes-Oxley Act and the rules and regulations promulgated thereunder.  Neither the Company nor, to the Company’s knowledge, any representative of the Company has received or otherwise had or obtained knowledge of any complaint, allegation, assertion or claim, whether written or oral, regarding the accounting or auditing practices, procedures, methodologies or methods of the Company or their respective internal accounting controls, including any complaint, allegation, assertion or claim that the Company has engaged in questionable accounting or auditing practices, except for (a) any complaint, allegation, assertion or claim as has been resolved without any resulting change to the Company’s accounting or auditing practices, procedures, methodologies or methods of the Company or its internal accounting controls, (b) questions regarding such matters raised and resolved in the ordinary course in connection with the preparation and review of the Company’s financial statements and periodic reports and (c) comments that have been raised by the staff of the Commission.  To the Company’s knowledge, no attorney representing the Company, whether or not employed by the Company, has reported evidence of a material violation of securities laws, breach of fiduciary duty or similar violation by the Company or any of its officers, directors, employees or agents to the Board of Directors or any committee thereof or to any director or officer of the Company.  To the Company’s knowledge, no employee of the Company has provided or is providing information to any law enforcement agency regarding the commission or possible commission of any crime or the violation or possible violation of any applicable law.

 

  

24

  

 

(pp)         Representations and Warranties Relating to the PRC Subsidiaries.  Except as described on Schedule 3.1(pp):

 

(i)            The constitutional documents of the Subsidiaries that have been established under the laws of the PRC (the “PRC Subsidiaries”) are valid and have been duly approved by and registered with the relevant PRC Governmental Bodies.

 

(ii)            All material consents, approvals, authorizations or licenses requisite under Legal Requirements of the PRC for the due and proper establishment and operation of each PRC Subsidiary have been duly obtained from the relevant PRC Governmental Bodies and are in full force and effect.

 

(iii)           All filings and registrations with the PRC Governmental Bodies required in respect of each PRC Subsidiary and its capital structure and operations including, without limitation, as required, the registration with the PRC Ministry of Commerce or its local counterpart, the China Securities Regulatory Commission, the State Administration of Industry and Commerce or their respective local divisions, the State Administration of Foreign Exchange, applicable PRC tax bureau and customs authorities have been duly completed in accordance with the relevant PRC Legal Requirements, except where the failure to complete such filings and registrations does not, and would not, individually or in the aggregate, have a Material Adverse Effect.

 

(iv)           Each PRC Subsidiary has complied with all relevant Legal Requirements of the PRC regarding the contribution and payment of its registered share capital, the payment schedule of which has been approved by the relevant PRC Governmental Bodies.  All of the registered capital of each PRC Subsidiary has been timely contributed, such contribution has been duly verified by a certified accountant registered in the PRC and the accounting firm employing such accountant, and the report of the certified accountant evidencing such verification has been registered with the relevant Governmental Body.  There are no resolutions pending to increase the registered capital of any PRC Subsidiary.  Except as described in Schedule 3.1(pp), there are no outstanding rights of, or commitments made by, the Company or any Subsidiary to sell any equity interest in any PRC Subsidiary, or by any of the other shareholders of any PRC Subsidiary to sell any equity interest in such PRC Subsidiary.  To the extent that any direct or indirect shareholder of the Company or any of its Subsidiaries is subject to the jurisdiction of Circular 75 issued by the PRC State Administration of Foreign Exchange on October 21, 2005, including any amendment, implementing rules, or official interpretation thereof or any replacement, successor or alternative legislation having the same subject matter thereof (collectively “Circular 75”), each such shareholder has complied in all respects with Circular 75 and any related requirement of law, including without limitation, the completion of any applicable foreign exchange registration, settlement or remittance requirement therein.

 

  

25

  

 

(v)           Each PRC Subsidiary has not received any letter or notice from any relevant PRC Governmental Body notifying it of revocation of any licenses or qualifications issued to it or any subsidy granted to it by any PRC Governmental Body for non-compliance with the terms thereof or with applicable PRC Legal Requirements, or the lack of compliance or remedial actions in respect of the activities carried out by each PRC Subsidiary, except such revocation as does not, and would not, individually or in the aggregate, have a Material Adverse Effect.

 

(vi)           Each PRC Subsidiary has conducted its business activities within the permitted scope of business or has otherwise operated its business in compliance with all relevant Legal Requirements and with all requisite licenses and approvals granted by competent PRC Governmental Bodies other than such non-compliance that does not, and would not, individually or in the aggregate, have a Material Adverse Effect.

 

(vii)         As to licenses, approvals and government grants and concessions requisite or material for the conduct of any material part of each PRC Subsidiary’s business which is subject to periodic renewal, the Company has no knowledge of any reasons related to the each PRC Subsidiary for which such requisite renewals will not be granted by the relevant PRC Governmental Bodies.

 

(viii)         With regard to employment and staff or labor, each PRC Subsidiary has complied with all applicable Legal Requirements of the PRC in all material respects, including without limitation, those pertaining to welfare funds, social benefits, medical benefits, insurance, retirement benefits, pensions or the like, other than such non-compliance that do not, and would not, individually or in the aggregate, have a Material Adverse Effect.

 

3.2.           Representations and Warranties of the Investors.  Each Investor hereby, for itself and for no other Investor, makes the following representations and warranties as of the date hereof and as of the Closing Date to the Company:

 

(a)            Organization; Authority.  If such Investor is a business entity, such Investor is an entity duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization with the requisite corporate or partnership power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents to which it is a party or a signatory and otherwise to carry out its obligations thereunder.  The execution, delivery and performance by such Investor of the transactions contemplated by this Agreement has been duly authorized by all necessary corporate or, if such Investor is not a corporation, such partnership, limited liability company or other applicable like action, on the part of such Investor.  Each Transaction Document executed by such Investor has been duly executed by such Investor, and when delivered by such Investor in accordance with the terms hereof, will constitute the valid and legally binding obligation of such Investor, enforceable against it in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting generally the enforcement of, creditors’ rights and remedies or by other equitable principles of general application.

 

  

26

  

 

(b)           Investment Intent.  Such Investor is acquiring the Securities issuable to it under the Transaction Documents as principal for its own account and not with a view to or for distributing or reselling such Securities or any part thereof, without prejudice, however, to such Investor’s right at all times to sell or otherwise dispose of all or any part of such Securities in compliance with applicable federal and state securities laws.  Subject to the immediately preceding sentence, nothing contained herein shall be deemed a representation or warranty by such Investor to hold the Securities for any period of time.  Such Investor is acquiring the Securities hereunder in the ordinary course of its business.  Such Investor does not have any agreement or understanding, directly or indirectly, with any Person to sell or to distribute any of the Securities.

 

(c)            Investor Status.  Such Investor is not a registered broker-dealer under Section 15 of the Exchange Act.  Such Investor has such experience in business and financial matters that it is capable of evaluating the merits and risks of an investment in the Securities.  Such Investor acknowledges that an investment in the Securities is speculative and involves a high degree of risk.  If such Investor is a U.S. Investor, at the time such Investor was offered the Securities, it was, and at the date hereof it is, an “accredited investor” as defined in Rule 501(a) under the Securities Act, and such Investor has completed and executed the Investor Questionnaire attached as Exhibit G to the Memorandum.

 

(d)            General Solicitation.  Such Investor is not purchasing the Securities as a result of any advertisement, article, notice, meeting, or other communication regarding the Securities published in any newspaper, magazine or similar media or broadcast over television or radio or presented at any seminar or any other general solicitation or general advertisement.

 

(e)            Access to Information.  Such Investor acknowledges that it has reviewed the Disclosure Materials and has been afforded (i) the opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Securities and the merits and risks of investing in the Securities; (ii) access to information about the Company and the Subsidiaries and their respective financial condition, results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make an informed investment decision with respect to the investment.  Neither such inquiries nor any other investigation conducted by or on behalf of such Investor or its representatives or counsel shall modify, amend or affect such Investor’s right to rely on the truth, accuracy and completeness of the Disclosure Materials and the Company’s representations and warranties contained in the Transaction Documents.

 

  

27

  

 

(f)            Certain Trading Activities.  Such Investor has not directly or indirectly, nor has any Person acting on behalf of or pursuant to any understanding with such Investor, engaged in any transactions in the securities of the Company (including, without limitations, any Short Sales involving the Company’s securities) since the earlier to occur of (1) the time that such Investor was first contacted by the Company, the Placement Agent, or any other Person acting on behalf of the Company regarding an investment in the Company and (2) the 30th day prior to the date of this Agreement.  Such Investor covenants that neither it nor any Person acting on its behalf or pursuant to any understanding with it will engage in any transactions in the securities of the Company (including Short Sales) prior to the time that the transactions contemplated by this Agreement are publicly disclosed.

 

(g)           Independent Investment Decision.  Such Investor has independently evaluated the merits of its decision to purchase the Securities pursuant to the Transaction Documents, and such Investor confirms that it has not relied on the advice of any other Investor’s business and/or legal counsel in making such decision.  Such Investor has not relied on the business or legal advice of the Placement Agent or any of its agents, counsel or Affiliates in making its investment decision hereunder, and confirms that none of such Persons has made any representations or warranties to such Investor in connection with the transactions contemplated by the Transaction Documents.

 

(h)           Reliance on Exemptions.  The Investor understands that the Securities are being offered and sold to it in reliance upon specific exemptions from the registration requirements of United States federal and state securities laws and that the Company is relying upon the truth and accuracy of, and the Investor’s compliance with, the representations, warranties, agreements, acknowledgments and understandings of the Investor set forth herein in order to determine the availability of such exemptions and the eligibility of the Investor to acquire the Securities.  All of the information which the Investor has provided to the Company is true, correct and complete as of the date this Agreement is signed, and if there should be any change in such information prior to the Closing, the Investor will immediately provide the Company with such information.

 

The Company acknowledges and agrees that no Investor has made or makes any representations or warranties with respect to the transactions contemplated hereby other than those specifically set forth in this Section 3.2.

 

ARTICLE 4.

OTHER AGREEMENTS OF THE PARTIES

 

4.1.           Transferability; Certificate.  (a) The Securities may only be disposed of in compliance with state and federal securities laws.  In connection with any transfer of the Securities other than pursuant to an effective registration statement, to the Company, to an Affiliate of an Investor or in connection with a pledge as contemplated in Section 4.1(b), the Company may require the transferor thereof to provide to the Company an opinion of counsel selected by the transferor, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer does not require registration of such transferred Securities under the Securities Act.

 

  

28

  

 

(b)           Certificates evidencing Securities will contain, in addition to the legend described in Section 3.2(i) as the case may be, the following legend, until such time as they are not required under Section 4.1(c):

 

THESE SECURITIES AND THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.  THESE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT SECURED BY SUCH SECURITIES.

 

The Company acknowledges and agrees that an Investor may from time to time pledge, and/or grant a security interest in some or all of the Securities pursuant to a bona fide margin agreement in connection with a bona fide margin account and, if required under the terms of such agreement or account, such Investor may transfer pledged or secured Securities to the pledgees or secured parties.  Such a pledge or transfer would not be subject to approval or consent of the Company and no legal opinion of legal counsel to the pledgee, secured party or pledgor shall be required in connection with the pledge, but such legal opinion may be required in connection with a subsequent transfer following default by the Investor transferee of the pledge.  No notice shall be required of such pledge.  At the appropriate Investor’s expense, the Company will execute and deliver such reasonable documentation as a pledgee or secured party of Securities may reasonably request in connection with a pledge or transfer thereof including the preparation and filing of any required prospectus supplement under Rule 424(b)(3) of the Securities Act or other applicable provision of the Securities Act to appropriately amend the list of selling stockholders thereunder.  Except as otherwise provided in Section 4.1(c), any Securities subject to a pledge or security interest as contemplated by this Section 4.1(b) shall continue to bear the legend set forth in this Section 4.1(b) and be subject to the restrictions on transfer set forth in Section 4.1(a).

 

  

29

  

 

(c)           Certificates evidencing Securities shall not contain any legend (including the legend set forth in Section 4.1(b)):  (i) while a registration statement (including the Registration Statement) covering such Securities is then effective, or (ii) following a sale or transfer of such Securities pursuant to Rule 144 (assuming the transferee is not an Affiliate of the Company), or (iii) while such Securities are eligible for sale by the selling Investor without volume restrictions under Rule 144.  The Company agrees that following the Effective Date or such other time as legends are no longer required to be set forth on certificates representing Securities under this Section 4.1(c), it will, no longer than three Trading Days following the delivery by an Investor to the Company or the Transfer Agent of a certificate representing such Securities containing a restrictive legend, deliver or instruct the Transfer Agent to deliver to such Investor, Securities which are free of all restrictive and other legends.  If the Company is then eligible, certificates for Securities subject to legend removal hereunder shall be transmitted by the Transfer Agent to an Investor by crediting the prime brokerage account of such Investor with the Depository Trust Company System as directed by such Investor.  If an Investor shall make a sale or transfer of Securities either (x) pursuant to Rule 144 or (y) pursuant to a registration statement and in each case shall have delivered to the Company or the Company’s transfer agent the certificate representing the applicable Securities containing a restrictive legend which are the subject of such sale or transfer and a representation letter in customary form (the date of such sale or transfer and Securities delivery being the “Securities Delivery Date”) and (1) the Company shall fail to deliver or cause to be delivered to such Investor a certificate representing such Securities that is free from all restrictive or other legends by the third Trading Day following the Securities Delivery Date and (2) following such third Trading Day after the Securities Delivery Date and prior to the time such Securities are received free from restrictive legends, the Investor, or any third party on behalf of such Investor, purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by the Investor of such Securities (a “Buy-In”), then, in addition to any other rights available to the Investor under the Transaction Documents and applicable law, the Company shall pay in cash to the Investor (for costs incurred either directly by such Investor or on behalf of a third party) the amount by which the total purchase price paid for Common Stock as a result of the Buy-In (including brokerage commissions, if any) exceed the proceeds received by such Investor as a result of the sale to which such Buy-In relates.  The Investor shall provide the Company written notice indicating the amounts payable to the Investor in respect of the Buy-In.  The Company may not make any notation on its records or give instructions to any transfer agent of the Company that enlarge the restrictions on transfer set forth in this Section.

 

4.2.           Furnishing of Information.  As long as any Investor or any transferee owns any Securities, the Company covenants to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to the Exchange Act.  As long as any Investor owns Securities, if the Company is not required to file reports pursuant to such laws, it will prepare and furnish to the Investors and make publicly available in accordance with Rule 144(c) such information as is required for the Investors to sell the Securities under Rule 144.  The Company further covenants that it will take such further action as any holder of Securities may reasonably request, all to the extent required from time to time to enable such Person to sell the Securities without registration under the Securities Act within the limitation of the exemptions provided by Rule 144.

 

  

30

  

 

4.3.           Integration.  The Company shall not, and shall use its best efforts to ensure that no Affiliate of the Company shall, sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would require the registration under the Securities Act of the sale of the Securities to the Investors, or that would be integrated with the offer or sale of the Securities for purposes of the rules and regulations of any Trading Market in a manner that would require stockholder approval of the sale of the Securities to the Investors.

 

4.4.           Subsequent Registrations.  Other than pursuant to the Registration Rights Agreement and as set forth on Schedule 4.4, prior to the first to occur of (a) the Effective Date of a Registration Statement resulting in all Registrable Securities (as defined in the Registration Rights Agreement) being registered for resale pursuant to one or more effective Registration Statements or (b) such time as all Registrable Securities may be sold by the Investors without volume restrictions pursuant to Rule 144, the Company may not file any registration statement (other than on Form S-8) with the Commission with respect to any securities of the Company.

 

4.5.           Securities Laws Disclosure; Publicity.  By (i) 9:30 a.m. (New York time) on the Trading Day following the Closing Date, the Company shall issue a press release, disclosing the transactions contemplated by the Transaction Documents and the Closing and by (ii) 5:30 p.m. (New York time) on the Trading Day following the Closing Date, the Company will file a Current Report on Form 8-K, disclosing the material terms of the Transaction Documents (and attach as exhibits thereto all existing Transaction Documents) and the Closing.  The Company covenants that following such disclosure, the Investors shall no longer be in possession of any material, non-public information with respect to the Company or any Subsidiary.  In addition, the Company will make such other filings and notices in the manner and time required by the Commission and the Trading Market on which the Common Stock is listed.  Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Investor, or include the name of any Investor in any filing with the Commission (other than the Registration Statement and any exhibits to filings made in respect of this transaction in accordance with periodic filing requirements under the Exchange Act) or any regulatory agency or Trading Market, without the prior written consent of such Investor, except to the extent such disclosure is required by law or Trading Market regulations.

 

4.6.           Pre-emptive Rights.  Until the expiration of the 12-month period following the Effective Date, the Investors shall have the right to purchase in any other equity or equity-linked offering conducted by the Company during such period that amount of securities, which are the subject of such offering, as will preserve such Investor’s percentage ownership of the Company as such Investor has upon completion of the Final Closing under this Agreement.  Any such purchase shall be on the same terms and subject to the same limitations as are included in the Offering.  The Company shall provide Investors with not less than 20-days’ notice of such Offering.

 

  

31

  

 

4.7.           Indemnification of Investors.  In addition to the indemnity provided in the Registration Rights Agreement, the Company will indemnify and hold the Investors, the Investor Representative, and their respective directors, officers, shareholders, partners, members, affiliates, employees and agents (each, an “Investor Party”) harmless from any and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court costs and reasonable attorneys’ fees and costs of investigation in respect thereof (collectively, “Losses”) that any such Investor Party may suffer or incur as a result of or relating to any misrepresentation, breach or inaccuracy of any representation, warranty, covenant or agreement made by any of the Company in any Transaction Document.  In addition to the indemnity contained herein, the Company will reimburse each Investor Party for its reasonable legal and other expenses (including the cost of any investigation, preparation and travel in connection therewith) incurred in connection therewith, as such expenses are incurred.  Except as otherwise set forth herein, the mechanics and procedures with respect to the rights and obligations under this Section 4.7 shall be the same as those set forth in Section 5 of the Registration Rights Agreement.

 

4.8.           Non-Public Information.  The Company covenants and agrees that, except as specifically contemplated by the Transaction Documents, neither it nor any other Person acting on its behalf will provide any Investor or its agents or counsel with any information that the Company believes constitutes material non-public information, unless prior thereto such Investor shall have executed a written agreement regarding the confidentiality and use of such information.  The Company understands and confirms that each Investor shall be relying on the foregoing representations in effecting transactions in securities of the Company.

 

4.9.           Use of Proceeds.  The Company will use the net proceeds from the sale of the Securities hereunder to support capital expenditures, provide capital for acquisition opportunities and for working capital, and not for the satisfaction of any portion of the Company’s debt (other than payment of trade payables and accrued expenses in the ordinary course of the Company’s business and consistent with prior practices), or to redeem any Common Stock or Common Stock Equivalents.

 

4.10.         Make Good Shares.

 

(a)           The Make Good Pledgor agrees that in the event that (i) the net revenue of the Company reported for the existing business segments (excluding any future acquisitions) in the Annual Report of the Company on Form 10-K (or such other form appropriate for such purpose as promulgated by the Commission) for the fiscal year ending December 31, 2011, as filed with the Commission (the “2011 Annual Report”), is less than $81,300,000 for the fiscal year ending December 31, 2011 (the “2011 Guaranteed Amount”) or (ii) the net revenue of the Company reported for the existing business segments (excluding any future acquisitions) in the Annual Report of the Company on Form 10-K (or such other form appropriate for such purpose as promulgated by the Commission) for the fiscal year ending December 31, 2012, as filed with the Commission (the “2012 Annual Report”), is less than $102,000,000 for the fiscal year ending December 31, 2012 (the “2012 Guaranteed Amount”), then in either case, the Make Good Escrow Agent (on behalf of the Make Good Pledgor) will, without any further action on the part of the Investors, transfer a number of Make Good Shares (as calculated below) to the Investors on a pro-rata basis (determined by dividing each Investor’s Investment Amount by the aggregate of all Investment Amounts delivered to the Company by the Investors hereunder) as specified in Exhibit A to this Agreement for no consideration other than payment of their respective Investment Amount paid to the Company at Closing.  If the net revenue of the Company for the existing business segments (excluding any future acquisitions) for the fiscal year ended December 31, 2011 equals or exceeds the 2011 Guaranteed Amount, then 50% of the Make Good Shares will be released back to the Make Good Pledgor.  The “Make Good Shares” means 500,000 shares of Common Stock owned by the Make Good Pledgor.  The number of Make Good Shares transferable to Investors shall be calculated as follows:

 

  

32

  

 

(i)           For the fiscal year ending December 31, 2011, the number of Make Good Shares transferable to Investors shall be equal to (A) the 2011 Guaranteed Amount less the actual net revenues of the Company for the existing business segments (excluding any future acquisitions) as reflected in the 2011 Annual Report, divided by (B) the 2011 Guaranteed Amount multiplied by the aggregate number of Make Good Shares; and

 

(ii)           For the fiscal year ending December 31, 2012, the number of Make Good Shares transferable to Investors shall be equal to (A) the 2012 Guaranteed Amount less the actual net revenues of the Company for the existing business segments (excluding any future acquisitions) as reflected in the 2012 Annual Report, divided by (B) the 2012 Guaranteed Amount multiplied by the aggregate number of remaining Make Good Shares that have not been released to the Make Good Pledgor or transferred to the Investors.

 

If the net revenue of the Company for the existing business segments (excluding any future acquisitions) for the fiscal year ended December 31, 2012 equals or exceeds the 2012 Guaranteed Amount, then the remaining Make Good Shares not previously released to the Make Good Pledgor or transferred to the Investors will be released back to the Make Good Pledgor.

 

(b)           Any required transfer of the Make Good Shares under this Section shall be made to the Investors or the Make Good Pledgor, as applicable, within 20 calendar days after the date on which the 2012 Annual Report or 2012 Annual Report, as applicable, is filed with the Commission and otherwise in accordance with the Make Good Escrow Agreement.

 

  

33

  

 

(c)           Notwithstanding the foregoing or anything else to the contrary herein, for purposes of determining whether or not the 2011 Guaranteed Amount or the 2012 Guaranteed Amount, as applicable, has been met, the Company may disregard any compensation charge or expense required to be recognized by the Company under GAAP resulting from the release of the Make Good Shares to the Make Good Pledgor if and to the extent such charge or expense is specified in the Company’s financial statements for the relevant year, as filed with the Commission.  In determining whether the Company has achieved the 2011 Guaranteed Amount or the 2012 Guaranteed Amount, as applicable, any liquidated damages payable pursuant to the Transaction Documents shall not be included as expenses of the Company.

 

(d)           The Company and the Make Good Pledgor shall notify the Investors as soon as the Make Good Shares have been deposited with the Make Good Escrow Agent.  Each of the Company and the Make Good Pledgor covenants and agrees that upon any transfer of Make Good Shares to the Investors in accordance with the Make Good Escrow Agreement, the Company and the Make Good Pledgor shall promptly instruct its transfer agent to reissue such Make Good Shares in the applicable Investor’s name and deliver the same as directed by such Investor.

 

(e)           The Investors hereby appoint the Investor Representative to act on their collective behalf with respect to all matters related to the Make Good Shares within the scope of this Section 4.10 and the Make Good Escrow Agreement, and the Investor Representative hereby accepts such appointment.  All decisions of the Investor Representative with respect to the subject matter of this Section 4.10 shall be binding on the Investors absent fraud or willful misconduct.

 

(f)            If any term or provision of this Section 4.10 contradicts or conflicts with any term or provision of the Make Good Escrow Agreement, the terms of the Make Good Escrow Agreement shall control.

 

(g)           In connection with the foregoing, the Make Good Pledgor agrees that within five (5) Trading Days following the Closing, the Make Good Pledgor will deposit 500,000 shares of Common Stock into escrow in accordance with the Make Good Escrow Agreement.

 

(h)           The Company agrees that any Make Good Shares to be issued to the Investors will be properly treated for United States tax purposes as constituting a non-taxable purchase price adjustment within the meaning of U.S. Treasury Regulation Section 1.305-1(c) and, accordingly, the Company shall effect all applicable tax reporting and all withholding tax determinations on a basis consistent with such non-taxable purchase price adjustment treatment.

 

(i)            If the Company shall at any time after the date hereof (A) declare and pay a dividend or make a distribution on Common Stock, or (B) subdivide or split the outstanding shares of Common Stock into a greater number of shares, or (C) combine or reclassify the outstanding shares of Common Stock into a smaller number of shares, or (D) make any other similar changes to its share capital (each of (A), (B), (C) and (D), a “Share Adjustment Event”), the Investors shall be entitled to receive the proportionately adjusted number of Make Good Shares and all dividends and other distributions made on the Make Good Shares that the Investors would have received had the Investors received such Make Good Shares at their applicable Closing.

 

  

34

  

 

4.11.         Post-Closing Covenants.

 

(a)           Government Approvals.  The Company agrees to use its commercially reasonable best efforts to obtain or cause its subsidiaries, affiliates and third party to obtain all requisite licenses and approvals granted by competent PRC Governmental Bodies for each PRC Subsidiary to conduct its business activities.

 

(b)           Deposit of Make Good Shares.  Within five (5) Trading Days after the Closing, the Make Good Pledgor shall have deposited 500,000 shares of Common Stock (which shall be equitably adjusted for any stock splits, stock combinations, stock dividends or similar transactions) into escrow in accordance with the Make Good Escrow Agreement along with bank signature stamped stock powers executed in blank (or such other signed instrument of transfer acceptable to the Company’s transfer agent).

 

(c)           Trust Arrangements.  Within twenty eight (28) days after the Closing, the Company will take such action as may be required by the Investor Representative to modify certain trust arrangements that were entered into among significant stockholders of record of the Company and/or its Subsidiaries and the beneficial owners of such record interests, to the satisfaction of the Investor Representative.

 

(d)           By-laws.  Within sixty (60) days of the Closing Date The Company will amend its by-laws to be in compliance with the listing standards of NASDAQ or NYSE Amex, or such other national exchange as the Company’s securities are listed or quoted on, or any other applicable laws or regulations.  Prior to adoption, such by-laws will be subject to review and approval by the Investor Representative, which approval will not be unreasonably withheld, conditioned or delayed.

 

(e)            Chief Financial Officer.  The Company will use its best efforts to hire an English-speaking Chief Financial Officer with U.S. GAAP experience within 120 days of the First Closing Date.

 

(f)            Investor Relations.  The Company shall set aside $240,000 of the proceeds of the Offering in an escrow account for the purpose of paying expenses for investor relations activities and in connection therewith will retain the services of a nationally recognized investor relations firm within 120 days from any Final Closing Date under this Agreement.

 

(g)           Listing of Common Stock.  The Company agrees, (i) to use its best efforts to cause the listing of its Common Stock, including the Shares, for trading on a National Exchange within 180 days of the First Closing Date, (ii) to take all action reasonably necessary to continue the present trading of its Common Stock on a Trading Market, and (iii) to comply in all material respects with the Company’s reporting, filing and other obligations under the bylaws or rules of any Trading Market on which shares of its Common Stock are listed and/or traded.

 

  

35

  

 

ARTICLE 5.

CONDITIONS PRECEDENT TO CLOSING

 

5.1.           Conditions Precedent to the Obligations of the Investors to Purchase Securities.  The obligation of the Investors to acquire Securities at the Closing is subject to the satisfaction or waiver by the Investor Representative, at or before the Closing, of each of the following conditions:

 

(a)           Representations and Warranties.  The representations and warranties of the Company contained herein shall be true and correct in all material respects as of the date when made and as of the Closing as though made on and as of such date;

 

(b)           Performance.  The Company shall have performed, satisfied and complied in all material respects with all covenants, agreements and conditions required by the Transaction Documents to be performed, satisfied or complied with by it at or prior to the Closing;

 

(c)           No Injunction.  No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed by any court or governmental authority of competent jurisdiction that prohibits the consummation of any of the transactions contemplated by the Transaction Documents;

 

(d)           Adverse Changes.  Since the date of execution of this Agreement, no event or series of events shall have occurred that reasonably could have or result in a Material Adverse Effect or a material adverse change with respect to the Company or the Subsidiaries;

 

(e)           Company Agreements.  The Company shall have delivered:

 

(i)            This Agreement, duly executed by the Company;

 

(ii)           The Closing Escrow Agreement, duly executed by the Company and the Escrow Agent;

 

(iii)           The Make Good Escrow Agreement, duly executed by the all parties thereto (other than the Placement Agent) and

 

(iv)           The Registration Rights Agreement, duly executed by the Company.

 

(f)           Company Deliverables.  The Company shall have delivered the Company Deliverables in accordance with Section 2.3(a);

 

  

36

  

 

(g)           Approvals.  The Company shall have obtained any and all consents, permits, approvals, registrations and waivers necessary or appropriate for consummation of the purchase and sale of the Securities and the consummation of the other transactions contemplated by the Transaction Documents, all of which shall be in full force and effect;

 

(h)           Stop Orders.  No stop order or suspension of trading shall have been imposed by the Commission or any other governmental or regulatory body having jurisdiction over the Company or the market(s) where the Common Stock is listed or quoted, with respect to public trading in the Common Stock; and

 

(i)            Termination.  This Agreement shall not have been terminated as to such Investor in accordance with Section 6.5.

 

5.2.           Conditions Precedent to the Obligations of the Company to Sell Securities.  The obligation of the Company to sell Securities at the Closing is subject to the satisfaction or waiver by the Company, at or before the Closing, of each of the following conditions:

 

(a)           Representations and Warranties.  The representations and warranties of each Investor contained herein shall be true and correct in all material respects as of the date when made and as of the Closing Date as though made on and as of such date;

 

(b)           Performance.  Each Investor shall have performed, satisfied and complied in all material respects with all covenants, agreements and conditions required by the Transaction Documents to be performed, satisfied or complied with by such Investor at or prior to the Closing;

 

(c)           No Injunction.  No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed by any court or governmental authority of competent jurisdiction that prohibits the consummation of any of the transactions contemplated by the Transaction Documents;

 

(d)           Investor Deliverables.  Each Investor shall have delivered this Agreement and the Registration Rights Agreement, each duly executed by such Investor and a completed Selling Holder Questionnaire (as defined in the Registration Rights Agreement).  Each U.S. Investor shall have delivered a duly completed Investor Questionnaire in the form attached as Exhibit G to the Memorandum.

 

(e)           Minimum Amount.  The Minimum Amount shall have been raised; and

 

(f)           Termination.  This Agreement shall not have been terminated as to such Investor in accordance with Section 6.5.

 

  

37

  

 

ARTICLE 6.

MISCELLANEOUS

 

6.1.           Fees and Expenses.  Each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery and performance of the Transaction Documents.  The Company shall pay all stamp and other taxes and duties levied in connection with the sale of the Securities.

 

6.2.           Entire Agreement.  The Transaction Documents, together with the Exhibits and Schedules thereto, contain the entire understanding of the parties with respect to the subject matter hereof and supersede all prior agreements, understandings, discussions and representations, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.

 

6.3.           Notices.  Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication is delivered via (i) facsimile (provided the sender receives a machine-generated confirmation of successful transmission) at the facsimile number specified in this Section or (ii) electronic mail (i.e., Email) prior to 6:30 p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the date of transmission, if such notice or communication is delivered via (i) facsimile at the facsimile number specified in this Section or (ii) electronic mail (i.e., Email) on a day that is not a Trading Day or later than 6:30 p.m. (New York City time) on any Trading Day, or (c) the Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (d) upon actual receipt by the party to whom such notice is required to be given, if sent by any means other than facsimile or Email transmission.  The address for such notices and communications shall be as follows:

 

	
If to the Company:

	
U.S. China Mining Group, Inc.

17890 Castleton Street, Suite 112

City of Industry, CA  91748

Facsimile: 626-965-0080

Attn.:  Mr. Hongwen Li

	 	 
	
With a copy to:

	
McKenna Long & Aldridge LLP

303 Peachtree Street, NE, Suite 5300

Atlanta, GA  30308

Facsimile:  404-527-8890

Attn.:  Thomas Wardell, Esq.

 

  

38

  

 

	
If to the Investor 

Representative:

	
Euro Pacific Capital, Inc.

88 Post Road West, 3rd Floor

Westport, CT 06880

Attention:  Mr. Thomas Tan

Facsimile:  (203) 662-9771

	 	 
	
With a copy to:

	
Pillsbury Winthrop Shaw Pittman LLP

2300 N Street NW

Washington, D.C. 20037

Facsimile:  202-663-8007

Attn.:  Louis A. Bevilacqua, Esq.

 

or such other address as may be designated in writing hereafter, in the same manner, by such Person.

 

6.4.           Amendments; Waivers.  No provision of this Agreement may be waived or amended except in a written instrument signed, in the case of an amendment, by the Company and the Investor Representative or, in the case of a waiver, by the party against whom enforcement of any such waiver is sought (and if such party is the Investors, then by the Investor Representative).  No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of either party to exercise any right hereunder in any manner impair the exercise of any such right.

 

6.5.           Termination.  This Agreement may be terminated prior to Closing:

 

(a)            by written agreement of the Investor Representative and the Company, a copy of which shall be provided to the Escrow Agent; and

 

(b)           by the Company or an Investor (as to itself but no other Investor) upon written notice to the other, with a copy to the Escrow Agent, if the Closing shall not have taken place by 6:30 p.m. Eastern time within the time period set forth in the Memorandum; provided, that the right to terminate this Agreement under this Section 6.5(b) shall not be available to any Person whose failure to comply with its obligations under this Agreement has been the cause of or resulted in the failure of the Closing to occur on or before such time.

 

In the event of a termination pursuant to Section 6.5(a) or 6.5(b), each Investor shall have the right to a return of up to its entire Investment Amount deposited with the Escrow Agent pursuant to Section 2.3(c), without interest or deduction.  The Company covenants and agrees to cooperate with such Investor in obtaining the return of its Investment Amount, and shall not communicate any instructions to the contrary to the Escrow Agent.

 

In the event of a termination pursuant to this Section, the Company shall promptly notify all non-terminating Investors.  Upon a termination in accordance with this Section 6.5, the Company and the terminating Investor(s) shall not have any further obligation or liability (including as arising from such termination) to the other and no Investor will have any liability to any other Investor under the Transaction Documents as a result therefrom.

 

  

39

  

 

6.6.           Construction.  The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions hereof.  The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent, and no rules of strict construction will be applied against any party.  This Agreement shall be construed as if drafted jointly by the parties, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any provisions of this Agreement or any of the Transaction Documents.

 

6.7.           Successors and Assigns.  This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns.  The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of the Investors.  Any Investor may assign any or all of its rights under this Agreement to any Person to whom such Investor assigns or transfers any Securities, provided such transferee agrees in writing to be bound, with respect to the transferred Securities, by the provisions hereof that apply to the “Investors.”

 

6.8.           No Third-Party Beneficiaries.  This Agreement is intended for the benefit of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise set forth in Section 4.7 (as to each Investor Party).  Notwithstanding the foregoing, the Investor Representative may rely on the representations and warranties of the Company and the Investors set forth in this Agreement and is an intended third party beneficiary of this Agreement and shall have all of the rights of an “Investor” under this Agreement.

 

6.9.           Governing Law.  All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof.  Each party agrees that all Proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective Affiliates, employees or agents) shall be commenced exclusively in the New York Courts.  Each party hereto hereby irrevocably submits to the exclusive jurisdiction of the New York Courts for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of the any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Proceeding, any claim that it is not personally subject to the jurisdiction of any such New York Court, or that such Proceeding has been commenced in an improper or inconvenient forum.  Each party hereto hereby irrevocably waives personal service of process and consents to process being served in any such Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof.  Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law.  Each party hereto hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated hereby.  If either party shall commence a Proceeding to enforce any provisions of a Transaction Document, then the prevailing party in such Proceeding shall be reimbursed by the other party for its reasonable attorneys’ fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Proceeding.

 

  

40

  

 

6.10.         Survival.  The representations, warranties, agreements and covenants contained herein shall survive the Closing and the delivery of the Securities for 18 months following the Closing Date.

 

6.11.         Execution.  This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood that both parties need not sign the same counterpart.  In the event that any signature is delivered by facsimile or e-mail transmission, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or e-mail signature page were an original thereof.

 

6.12.         Severability.  If any provision of this Agreement is held to be invalid or unenforceable in any respect, the validity and enforceability of the remaining terms and provisions of this Agreement shall not in any way be affected or impaired thereby and the parties will attempt to agree upon a valid and enforceable provision that is a reasonable substitute therefor, and upon so agreeing, shall incorporate such substitute provision in this Agreement.

 

6.13.         Rescission and Withdrawal Right.  Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) the Transaction Documents, whenever any Investor exercises a right, election, demand or option under a Transaction Document and the Company does not timely perform its related obligations within the periods therein provided, then such Investor may rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election in whole or in part without prejudice to its future actions and rights.

 

6.14.         Replacement of Securities.  If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof, or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction and customary and reasonable indemnity, if requested.  The applicants for a new certificate or instrument under such circumstances shall also pay any reasonable third-party costs associated with the issuance of such replacement Securities.  If a replacement certificate or instrument evidencing any Securities is requested due to a mutilation thereof, the Company may require delivery of such mutilated certificate or instrument as a condition precedent to any issuance of a replacement.

 

  

41

  

 

6.15.         Remedies.  In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Investors and the Company will be entitled to specific performance under the Transaction Documents.  The parties agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations described in the foregoing sentence and hereby agrees to waive in any action for specific performance of any such obligation the defense that a remedy at law would be adequate.

 

6.16.         Payment Set Aside.  To the extent that the Company makes a payment or payments to any Investor pursuant to any Transaction Document or an Investor enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other person under any law (including, without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such payment had not been made or such enforcement or setoff had not occurred.

 

6.17.         Independent Nature of Investors’ Obligations and Rights.  The obligations of each Investor under any Transaction Document are several and not joint with the obligations of any other Investor, and no Investor shall be responsible in any way for the performance of the obligations of any other Investor under any Transaction Document.  The decision of each Investor to purchase Securities pursuant to the Transaction Documents has been made by such Investor independently of any other Investor.  Nothing contained herein or in any Transaction Document, and no action taken by any Investor pursuant thereto, shall be deemed to constitute the Investors as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Investors are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents.  Each Investor acknowledges that no other Investor has acted as agent for such Investor in connection with making its investment hereunder and that no Investor will be acting as agent of such Investor in connection with monitoring its investment in the Securities or enforcing its rights under the Transaction Documents.  Each Investor shall be entitled to independently protect and enforce its rights, including without limitation the rights arising out of this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Investor to be joined as an additional party in any proceeding for such purpose.  The Company acknowledges that each of the Investors has been provided with the same Transaction Documents for the purpose of closing a transaction with multiple Investors and not because it was required or requested to do so by any Investor.

 

  

42

  

 

6.18.         Limitation of Liability.  Notwithstanding anything herein to the contrary, the Company acknowledges and agrees that the liability of an Investor arising directly or indirectly, under any Transaction Document of any and every nature whatsoever shall be satisfied solely out of the assets of such Investor, and that no trustee, officer, other investment vehicle or any other Affiliate of such Investor or any investor, shareholder or holder of shares of beneficial interest of such a Investor shall be personally liable for any liabilities of such Investor.

 

[Signature Page Follows]

 

 

 

 

 

 

  

43

  

 

IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.

 

	 	
COMPANY:

	 	 
	 	
U.S. CHINA MINING GROUP, INC.

	 	  
	 	 
	 	 
	 	
By:

	
 

	 
	 	 	
Name:  Hongwen Li

	 
	 	 	
Title:    Chief Executive Officer

	 
	 	
 

	 	  
	 	 
	 	
Solely with respect to Section 4.10 herein:

	 	 
	 	
MAKE GOOD PLEDGOR

	 	 
	 	 
	 	 
	 	 	 
	 	
Yue Guoqing

	 
	 	  
	 	 
	 	 
	 	
INVESTORS:

	 	 
	 	
The Investors executing the Signature Page in the form attached hereto as Annex A and delivering the same to the Company or its agents shall be deemed to have executed this Agreement and agreed to the terms hereof.

	 	 
	 	
Solely with respect to Sections 2.6, 5.1, 6.4, 6.5(a) and 6.8 herein:

	 	 
	 	
INVESTOR REPRESENTATIVE

	 	 
	 	
EURO PACIFIC CAPITAL, INC.

	 	  
	 	
By:

	  	 
	 	 	
Name:

	 	 	
Title:

 

  

  

  

 

Annex A

 

Securities Purchase Agreement

Investor Counterpart Signature Page

 

The undersigned, desiring to:  (i) enter into this Securities Purchase Agreement, dated as of _____________, 2010 (the “Agreement”), between the undersigned, U.S. China Mining Group, Inc., a Nevada corporation (the “Company”), and the other parties thereto, in or substantially in the form furnished to the undersigned and (ii) purchase the securities of the Company appearing below, hereby agrees to purchase such securities from the Company as of the Closing and further agrees to join the Agreement as a party thereto, with all the rights and privileges appertaining thereto, and to be bound in all respects by the terms and conditions thereof.

 

IN WITNESS WHEREOF, the undersigned has executed the Agreement as of ________________ ___, 2010.

 

	 	
Name and Address, Fax No. and Social Security No./EIN of Investor:

	 	  
	 	  
	 	  
	 	
Fax No.:

	 
	 	
Soc. Sec. No./EIN:  

	 
	 	
If a partnership, corporation, trust or other business entity:

	 	 
	 	
By:

	 	 
	 	Name:
	 	
Title:

	 	
 

	 	
If an individual:

	 	 
	 	
Signature:

	 
	 	 
	 	
Investment Amount: 

	 
	 	 
	 	
Amount of Units to be

Purchased: 

	
 

 

 

	
Account Registration Type (check one)

	
o Individual Account

	  	
o Joint Account

	  	
o Individual Retirement Account

	  	
o Corporation/Partnership/Other

	  	
o Trust

 

Annex A

 

  

  

  

 

EXHIBIT A

 

SCHEDULE OF INVESTORS

 

	
Name

	
Investment 

Amount

	
Number 

of Shares

	
Number of Shares 

Subject to 

Warrants

	
TASLIMI, MEHRAN M

	
 $          700,000

	
175,000

	
87,500

	
TASLIMI, SHIDAN

	
 $          700,000

	
175,000

	
87,500

	
RAVENEL III, BRUCE WALKER

	
 $          400,000

	
100,000

	
50,000

	
DAYBREAK SPECIAL SITUATIONS MASTER FUND

	
 $          300,000

	
75,000

	
37,500

	
POTAPCHUK, RICHARD

	
 $          300,000

	
75,000

	
37,500

	
MMH GROUP LLC

	
 $          200,000

	
50,000

	
25,000

	
WELSH, KERRY LEE & HELEN

	
 $          200,000

	
50,000

	
25,000

	
GUAGLIARDO, LARRY

	
 $          200,000

	
50,000

	
25,000

	
FELDMAN, GEORGE

	
 $          180,000

	
45,000

	
22,500

	
SCHIFF, PETER D

	
 $          160,000

	
40,000

	
20,000

	
RICHARDS, ELIZABETH

	
 $          150,000

	
37,500

	
18,750

	
WEAVER, TIMOTHY M

	
 $          150,000

	
37,500

	
18,750

	
LEARY, LAWRENCE

	
 $          150,000

	
37,500

	
18,750

	
COLTRIN, JOANNE & ANDRE

	
 $          110,000

	
27,500

	
13,750

	
NASS, ROLLOVER IRA FBO KENNETH HENRY

	
 $          110,000

	
27,500

	
13,750

	
DOMINGUEZ TRUST

	
 $          110,000

	
27,500

	
13,750

	
NOBLES, VADA

	
 $          100,000

	
25,000

	
12,500

	
NEIBERG, MARY

	
 $          100,000

	
25,000

	
12,500

	
POM INVESTMENTS LLC

	
 $          100,000

	
25,000

	
12,500

	
HEIMANN LIVING TR, ROBERT K

	
 $          100,000

	
25,000

	
12,500

 

  

A-1

  

 

	
MCINTYRE TRUST, ROD

	
 $          100,000

	
25,000

	
12,500

	
VDHF HOLDING CO

	
 $          100,000

	
25,000

	
12,500

	
SUTER FAMILY TRUST

	
 $          100,000

	
25,000

	
12,500

	
REISNER ROLLOVER IRA, FBO JEFFREY

	
 $          100,000

	
25,000

	
12,500

	
RICE ROLLOVER IRA, FBO MARSHALL CARL

	
 $          100,000

	
25,000

	
12,500

	
LADNER ROLLOVER IRA,  FBO THOMAS AARON

	
 $          100,000

	
25,000

	
12,500

	
VAL EYE CARE MED GRP FBO STAFF

	
 $          100,000

	
25,000

	
12,500

	
KK SWOGGER ASSET MANAGEMENT

	
 $          100,000

	
25,000

	
12,500

	
FRIESEN, WALTER

	
 $          100,000

	
25,000

	
12,500

	
TAMBORELLO ROLLOVER IRA, FBO JAMES A

	
 $          100,000

	
25,000

	
12,500

	
WAHL IRA, FBO HOWARD W

	
 $          100,000

	
25,000

	
12,500

	
KIRK, PATRICK & GLORIA

	
 $          100,000

	
25,000

	
12,500

	
PARKER, RUSSELL

	
 $          100,000

	
25,000

	
12,500

	
BACOLINI, VINCE

	
 $          100,000

	
25,000

	
12,500

	
COOPER, CAROL IMBT

	
 $          100,000

	
25,000

	
12,500

	
MCPHERSON, J MARK

	
 $          100,000

	
25,000

	
12,500

	
STEFANIK REVOCABLE TRUST, AMY J

	
 $          100,000

	
25,000

	
12,500

	
DREYER JR, JAMES D

	
 $          100,000

	
25,000

	
12,500

	
DREW & RASKIN P/S PLAN

	
 $             80,000

	
20,000

	
10,000

	
BRADBURY IRRVOC TR, JOSH D

	
 $             80,000

	
20,000

	
10,000

	
BRADBURY JR IRREV TRUST, JOSH D

	
 $             80,000

	
20,000

	
10,000

 

  

A-2

  

 

	
BRADBURY REVOCABLE TRUST

	
 $             80,000

	
20,000

	
10,000

	
BACON TRUST, JAMES V

	
 $             80,000

	
20,000

	
10,000

	
BROWN SEP IRA,  FBO JAMES CURTIS

	
 $             80,000

	
20,000

	
10,000

	
CREWS SEP IRA, FBO TERRY ALAN

	
 $             80,000

	
20,000

	
10,000

	
MEISTER NON-EXEMPT MARITAL TR

	
 $             80,000

	
20,000

	
10,000

	
MATULA FAMILY LP CLASS 2 A PARTNERSHIP

	
 $             80,000

	
20,000

	
10,000

	
LUNDBERG ROLLOVER IRA, FBO GERSHOM

	
 $             80,000

	
20,000

	
10,000

	
JACKSON IRA, FBO ROYCE V

	
 $             75,000

	
18,750

	
9,375

	
CATHRO TRUST, ROBERT E

	
 $             75,000

	
18,750

	
9,375

	
HANNON, TODD A & MICHELLE L

	
 $             72,000

	
18,000

	
9,000

	
FRANKLIN FAMILY TRUST, BRUCE A

	
 $             70,000

	
17,500

	
8,750

	
EVERETT, BLAKE & LISA

	
 $             70,000

	
17,500

	
8,750

	
SCULLY, MICHAEL

	
 $             70,000

	
17,500

	
8,750

	
SIMONS, EDGAR

	
 $             70,000

	
17,500

	
8,750

	
ZINK ROLLOVER IRA,  FBO PAUL HARPER

	
 $             60,000

	
15,000

	
7,500

	
LUTTER ROTH IRA, FBO JAMES ALLEN

	
 $             60,000

	
15,000

	
7,500

	
ADVANCED DERMATOLOGY ASSOC 401K

	
 $             60,000

	
15,000

	
7,500

	
KASSIN, MARC

	
 $             60,000

	
15,000

	
7,500

	
GALUZ JT LIVING TST, ALEXANDER & YANA

	
 $             60,000

	
15,000

	
7,500

	
MAY, FRANCIS BRENT & JONEITA JEAN

	
 $             58,000

	
14,500

	
7,250

 

  

A-3

  

 

	
BUKAMIER FAMILY TRUST

	
 $             50,000

	
12,500

	
6,250

	
DRELICK IRA,  FBO STANLEY J

	
 $             50,000

	
12,500

	
6,250

	
CLAUSSEN TRUST

	
 $             50,000

	
12,500

	
6,250

	
JOHNSON REV TRST, DOUGLAS WILLIAM

	
 $             50,000

	
12,500

	
6,250

	
FINEGOLD REVOCABL, JACK & TAMI

	
 $             50,000

	
12,500

	
6,250

	
MUNRO, PAMELA HARRINGTON

	
 $             50,000

	
12,500

	
6,250

	
MULLEN SEPERATE PRPRTY TR, PATRICK

	
 $             50,000

	
12,500

	
6,250

	
POINT AUX CHENES LLC

	
 $             50,000

	
12,500

	
6,250

	
BRABENAC, CHARLES

	
 $             50,000

	
12,500

	
6,250

	
SHEAHAN, JAMES A & MELODY K

	
 $             50,000

	
12,500

	
6,250

	
ARCHIBALD, JEFF

	
 $             50,000

	
12,500

	
6,250

	
MARK R MITCHELL MD A MEDICAL CORP DBPP

	
 $             50,000

	
12,500

	
6,250

	
AMERMAN, MATTHEW C  CARRIE

	
 $             50,000

	
12,500

	
6,250

	
PETERSON, TINA C & HENDRIKUS M SCHRAVEN

	
 $             50,000

	
12,500

	
6,250

	
EARL, BENJAMIN R & JONEE D

	
 $             50,000

	
12,500

	
6,250

	
LONG, CAROLYN R

	
 $             50,000

	
12,500

	
6,250

	
SULLIVAN, CHARLES & CAROL

	
 $             50,000

	
12,500

	
6,250

	
CLEARPATH LLC

	
 $             50,000

	
12,500

	
6,250

	
WARD, CLIFF

	
 $             50,000

	
12,500

	
6,250

	
MCNAMEE, COREY SHANNON

	
 $             50,000

	
12,500

	
6,250

	
CLARK JR, DONALD GIRARD & DEBRA L

	
 $             50,000

	
12,500

	
6,250

 

  

A-4

  

 

	
SCHAIRER JR, HENRY LOUIS

	
 $             50,000

	
12,500

	
6,250

	
EDWARDS, JONATHAN & VIRGINIA C ADAMS

	
 $             50,000

	
12,500

	
6,250

	
MCCARTHY, JOSEPH & MIKI

	
 $             50,000

	
12,500

	
6,250

	
SCOTT, KENT & LAURA

	
 $             50,000

	
12,500

	
6,250

	
O'NEILL, KEVIN P & SUZANNE ODELL

	
 $             50,000

	
12,500

	
6,250

	
MCHUGH, LAURA D

	
 $             50,000

	
12,500

	
6,250

	
LARSON FAMILY 2006 TRUST

	
 $             50,000

	
12,500

	
6,250

	
ALLSTATES DRYWALL INC EE S T

	
 $             50,000

	
12,500

	
6,250

	
MARTIN, MITCHELL & DEBORAH

	
 $             50,000

	
12,500

	
6,250

	
MONA ROLLOVER IRA, FBO GERALD

	
 $             50,000

	
12,500

	
6,250

	
TUMKO, OLEKSANDR & OKSANA

	
 $             50,000

	
12,500

	
6,250

	
DIPAOLO WORTHINGTON FAMILY TRUST

	
 $             50,000

	
12,500

	
6,250

	
SPADY, ROBERT NEAL & LINDA

	
 $             50,000

	
12,500

	
6,250

	
BASLER LIVING TRUST, SARAH J

	
 $             50,000

	
12,500

	
6,250

	
OLSON FAMILY TRUST

	
 $             50,000

	
12,500

	
6,250

	
CRANE TRUST, TIMOTHY R

	
 $             50,000

	
12,500

	
6,250

	
BRADLEY ANESTHESIOLOGY PSP

	
 $             50,000

	
12,500

	
6,250

	
KLEPPEN, ART & KIMBERLY

	
 $             50,000

	
12,500

	
6,250

	
BROWNE IRA,  FBO PAT

	
 $             50,000

	
12,500

	
6,250

	
WALKER ROLLOVER IRA,  FBO RUSSELL B

	
 $             50,000

	
12,500

	
6,250

	
GROFF LIVING TRUST

	
 $             50,000

	
12,500

	
6,250

	
YANO LOVING TRUST

	
 $             50,000

	
12,500

	
6,250

 

  

A-5

  

 

	
LARSON, DAVID W & JENNIFER L

	
 $             50,000

	
12,500

	
6,250

	
SPIELMAN AND ELKIN REV TR

	
 $             50,000

	
12,500

	
6,250

	
BARNEY REV TR, GERALD AND BEVERLY

	
 $             50,000

	
12,500

	
6,250

	
BRUNZLICK MEDICAL SERVICES INC

	
 $             50,000

	
12,500

	
6,250

	
HUNTSINGER IRA, BDA NSPS BERT JUDE

	
 $             50,000

	
12,500

	
6,250

	
SPOLUM IRA, FBO DIANE D

	
 $             50,000

	
12,500

	
6,250

	
MIGAS IRA, FBO MARYANN

	
 $             50,000

	
12,500

	
6,250

	
EDSON ROLLOVER IRA, FBO RALPH DALE

	
 $             50,000

	
12,500

	
6,250

	
HARMS ROLLOVER IRA, FBO STEVEN PAUL

	
 $             50,000

	
12,500

	
6,250

	
MADARAZ IRA, FBO GEORGE

	
 $             50,000

	
12,500

	
6,250

	
FOSS REV TR, ROBERT T & MARGARET

	
 $             50,000

	
12,500

	
6,250

	
MACCABEE TRUST

	
 $             50,000

	
12,500

	
6,250

	
CYR, WILLIAM J

	
 $             50,000

	
12,500

	
6,250

	
BUCKTHORN LLC

	
 $             50,000

	
12,500

	
6,250

	
BENSON LIVING TRUST, NANCY L

	
 $             50,000

	
12,500

	
6,250

	
SANDERS FAM TR REV TR, GAYLE M & DEBORAH

	
 $             50,000

	
12,500

	
6,250

	
KINZUA INVESTMENT CLUB

	
 $             50,000

	
12,500

	
6,250

	
GLASER JR ROLLOVER IRA, FBO DONALD T

	
 $             50,000

	
12,500

	
6,250

	
 SCULLY, DAVID ALAN

	
 $             50,000

	
12,500

	
6,250

	
NASS, IRA FBO TIMOTHY

	
 $             50,000

	
12,500

	
6,250

	
FOREMAN TRUST, DEBORAH D

	
 $             50,000

	
12,500

	
6,250

 

  

A-6

  

 

	
FRED HARPER LLC

	
 $             50,000

	
12,500

	
6,250

	
HEINKING, MARY

	
 $             50,000

	
12,500

	
6,250

	
DUNKUM III IRA,  FBO WILLIS

	
 $             50,000

	
12,500

	
6,250

	
KESSLER, CYNTHIA & JAMES

	
 $             50,000

	
12,500

	
6,250

	
MOHR TRUST, EDWARD CHARLES

	
 $             50,000

	
12,500

	
6,250

	
QMI FERTILIZER & GRAIN INC

	
 $             50,000

	
12,500

	
6,250

	
BISHOP, ROBERT L  TOD FRANCINE

	
 $             50,000

	
12,500

	
6,250

	
ELLIS IRA - BDA NSPS BARBARA

	
 $             50,000

	
12,500

	
6,250

	
NAHUM, ANTHONY

	
 $             50,000

	
12,500

	
6,250

	
SORGE JR IRA, FBO PAUL E

	
 $             50,000

	
12,500

	
6,250

	
KARAMAOUN, NICOLAS

	
 $             50,000

	
12,500

	
6,250

	
SCHEIN VENTURES LLC

	
 $             50,000

	
12,500

	
6,250

	
ROZOV, YADIN

	
 $             50,000

	
12,500

	
6,250

	
HEARST, BARBARA

	
 $             50,000

	
12,500

	
6,250

	
LEWIS DECL OF TRUST, CINDY J

	
 $             50,000

	
12,500

	
6,250

	
CARDILE SR, FRANK

	
 $             50,000

	
12,500

	
6,250

	
GARY MARDER DO TR ALLERGY DERMATOLOGY & SKIN INC

	
 $             50,000

	
12,500

	
6,250

	
GRIFFIN UTMA OH, DANIEL J

	
 $             50,000

	
12,500

	
6,250

	
GRIFFIN UTMA OH, MICHELLE E

	
 $             50,000

	
12,500

	
6,250

	
GRIFFIN, JULIA L

	
 $             50,000

	
12,500

	
6,250

	
SCHWARTZ, MIRIAM

	
 $             50,000

	
12,500

	
6,250

	
MUELLER, SCOTT

	
 $             50,000

	
12,500

	
6,250

	
GRIFFIN, SCOTT R

	
 $             50,000

	
12,500

	
6,250

	
SMITH, STEVE

	
 $             50,000

	
12,500

	
6,250

 

  

A-7

  

 

	
KLOECKNER, DARREL LEE

	
 $             50,000

	
12,500

	
6,250

	
STEPHEN P MCCARRON P C PFT SHRING PL

	
 $             50,000

	
12,500

	
6,250

	
RAWLINGS, JASON L & LEANNE K

	
 $             50,000

	
12,500

	
6,250

	
HSIAO, CHIN

	
 $             50,000

	
12,500

	
6,250

	
FRIED FAMILY TRUST

	
 $             50,000

	
12,500

	
6,250

	
THIARA FAMILY TRUST

	
 $             50,000

	
12,500

	
6,250

	
BELASCO, CHARLOTTE J

	
 $             50,000

	
12,500

	
6,250

	
KERENYI, JUSTIN

	
 $             50,000

	
12,500

	
6,250

	
OSTERHAUS REV TR, MARK A

	
 $             50,000

	
12,500

	
6,250

	
SCHORTMANN, PETER & SUSAN

	
 $             50,000

	
12,500

	
6,250

	
ANTHONY III, RICHARD P & KIMBERLY J

	
 $             50,000

	
12,500

	
6,250

	
GHAI, VIVEK

	
 $             50,000

	
12,500

	
6,250

	
KIENE, HEIDI W & KEVIN

	
 $             40,000

	
10,000

	
5,000

	
SCOTT R LENNES IRA LLC

	
 $             40,000

	
10,000

	
5,000

	
WILEY FAMILY LIVING TRUST

	
 $             40,000

	
10,000

	
5,000

	
MOORE, RICHARD

	
 $             40,000

	
10,000

	
5,000

	
CARROLL, TIMOTHY

	
 $             40,000

	
10,000

	
5,000

	
KEALY REVOCABLE TRUST, JOHN T

	
 $             40,000

	
10,000

	
5,000

	
GLEASON, KENNETH RAY

	
 $             40,000

	
10,000

	
5,000

	
GLEASON, RANDELL SCOTT & MICHELE LEE

	
 $             40,000

	
10,000

	
5,000

	
BIZ, TONY &  JEANNE C LIM

	
 $             40,000

	
10,000

	
5,000

	
BEESON, CURTIS ANDREW & BRENDA BATENBURG

	
 $             40,000

	
10,000

	
5,000

 

  

A-8

  

 

	
ABRAMS PENSION PLAN 1, JACK

	
 $             40,000

	
10,000

	
5,000

	
GADOL DMD PSP

	
 $             40,000

	
10,000

	
5,000

	
SURERUS IRA, FBO GERARD

	
 $             40,000

	
10,000

	
5,000

 

 

 

 

 

 

 

  

A-9

  

 

EXHIBIT B

 

REGISTRATION RIGHTS AGREEMENT

 

 

 

 

 

 

  

B-1

  

 

EXHIBIT C

 

CLOSING ESCROW AGREEMENT

 

 

 

 

 

 

  

C-1

  

 

EXHIBIT D

 

MAKE GOOD ESCROW AGREEMENT

 

 

 

 

 

 

  

D-1

  

 

EXHIBIT E

 

COMMON STOCK PURCHASE WARRANT

 

 

 

 

E-1ex10_2.htm

Exhibit 10.2

 

REGISTRATION RIGHTS AGREEMENT

 

This REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of January 7, 2011, by and among U.S. China Mining Group, Inc., a Nevada corporation (the “Company”), the investors identified on Schedule A hereto (each, including their respective successors and assigns, an “Investor” and collectively, the “Investors”) and, with respect to certain sections hereof, Euro Pacific Capital, Inc. (the “Investor Representative”).

 

WHEREAS, in connection with the Securities Purchase Agreement by and among the parties hereto of even date herewith (the “Purchase Agreement”), the Company has agreed, upon the terms and subject to the conditions set forth in the Purchase Agreement, to issue and sell to each Investor units comprised of (i) one share of the Company’s common stock, $0.001 par value per share (the “Common Stock”) in the principal amount of $10,000 and (ii) one Warrant to purchase .5 shares of the Common Stock at an exercise price of $6.80 per share; and

 

WHEREAS, in accordance with the terms of the Purchase Agreement, the Company has agreed to provide certain registration rights under the Securities Act of 1933, as amended, and the rules and regulations thereunder, or any similar successor statute (collectively, the “Securities Act”), and applicable state securities laws.

 

NOW, THEREFORE, in consideration of the premises and the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and each of the Investors hereby agree as follows:

 

1.           Definitions.  Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement will have the respective meanings given such terms in the Purchase Agreement.  As used in this Agreement, the following terms have the respective meanings set forth in this Section 1:

 

“Advice” has the meaning set forth in Section 8(e).

 

“Commission Comments” means written comments pertaining solely to Rule 415 which are received by the Company from the Commission to a filed Registration Statement, which either (i) requires the Company to limit the number of Registrable Securities which may be included therein to a number which is less than the number sought to be included thereon as filed with the Commission or (ii) requires the Company to either exclude Registrable Securities held by specified Holders or deem such Holders to be underwriters with respect to Registrable Securities they seek to include in such Registration Statement.

 

“Cut Back Shares” has the meaning set forth in Section 2(b).

 

“Effective Date” means, as to a Registration Statement, the date on which such Registration Statement is first declared effective by the Commission.

 

  

  

  

 

“Effectiveness Date” means (a) with respect to the initial Registration Statement required to be filed pursuant to Section 2(a), the earlier of:  (i) the 150th day following the Final Closing Date and (ii) the fifth Trading Day following the date on which the Company is notified by the Commission that the initial Registration Statement will not be reviewed or is no longer subject to further review and comments; (b) with respect to any additional Registration Statements required to be filed pursuant to Section 2(a), the earlier of:  (i) the 150th day following the applicable Filing Date for such additional Registration Statement(s) and (ii) the fifth Trading Day following the date on which the Company is notified by the Commission that such additional Registration Statement(s) will not be reviewed or is no longer subject to further review; (c) with respect to any additional Registration Statements required to be filed solely due to SEC Restrictions, the earlier of:  (i) the 150th day following the applicable Restriction Termination Date and (ii) the fifth Trading Day following the date on which the Company is notified by the Commission that such Registration Statement will not be reviewed or is no longer subject to further review and comments; (d) with respect to a Registration Statement required to be filed under Section 2(c), the earlier of:  (i) the 150th day following the date on which the Company becomes eligible to utilize Form S-3 to register the resale of Common Stock; provided, that, if the Commission reviews and has written comments to any filed Registration Statement described in Section 2 that would require the filing of a pre-effective amendment thereto with the Commission, then the Effectiveness Date under this clause shall be the 180th day following the Final Closing Date; and (ii) the fifth Trading Day following the date on which the Company is notified by the Commission that the Registration Statement will not be reviewed or is no longer subject to further review and comments; and (e) with respect to a Registration Statement required to be filed under Section 2(d), the earlier of:  (i) the 150th day following the Make Good Shares Delivery Date; provided, that, if the Commission reviews and has written comments to any filed Registration Statement described in Section 2 that would require the filing of a pre-effective amendment thereto with the Commission, then the Effectiveness Date under this clause (e)(i) shall be the 180th day following the Make Good Shares Delivery Date; and (ii) the fifth Trading Day following the date on which the Company is notified by the Commission that the Registration Statement will not be reviewed or is no longer subject to further review and comments.

 

“Effectiveness Period” means, as to any Registration Statement required to be filed pursuant to this Agreement, the period commencing on the Effective Date of such Registration Statement and ending on (a) the date that all of the Registrable Securities covered by such Registration Statement have been publicly sold by the Holders of the Registrable Securities included therein, or (b) such time as all of the Registrable Securities covered by such Registration Statement may be sold by the Holders without volume restrictions pursuant to Rule 144 as determined by the counsel to the Company pursuant to a written opinion letter to such effect, addressed and acceptable to the Company’s transfer agent and the affected Holders.

 

“Exchange Act” means the Securities Exchange Act of 1934, as amended.

 

“Filing Date” means (a) with respect to the initial Registration Statement required to be filed pursuant to Section 2(a), the 45th day following the Final Closing Date; (b) with respect to any additional Registration Statements required to be filed pursuant to Section 2(a), the 45th day following the Effective Date for the last Registration Statement filed pursuant to this Agreement under Section 2(a); (c) with respect to any additional Registration Statements required to be filed due to SEC Restrictions, the 45th day following the applicable Restriction Termination Date; (d) with respect to a Registration Statement required to be filed under Section 2(c), the 45th day following the date on which the Company becomes eligible to utilize Form S-3 to register the resale of Common Stock; and (e) with respect to the Registration Statement required to be filed under Section 2(d), the 45th day following the Make Good Shares Delivery Date.

 

  

2

  

 

“FINRA” means the Financial Industry Regulatory Authority, Inc.

 

“Holder” or “Holders” means the holder or holders, as the case may be, from time to time of Registrable Securities and, if other than an Investor, a Person to whom the rights hereunder have been properly assigned pursuant to Section 7 hereof.

 

“Indemnified Party” has the meaning set forth in Section 5(c).

 

“Indemnifying Party” has the meaning set forth in Section 5(c).

 

“Investment Amount” means, with respect to each Investor, the Investment Amount indicated on such Investor’s signature page to this Agreement, which is also reflected on the Schedule of Investors attached hereto as Schedule A.

 

“Losses” has the meaning set forth in Section 5(a).

 

“Make Good Shares Delivery Date” means the date on which the Make Good Shares are required to be delivered to the Investors pursuant to the Make Good Escrow Agreement.

 

“New York Courts” means the state and federal courts sitting in the City of New York, Borough of Manhattan.

 

“Proceeding” means an action, claim, suit, investigation or proceeding (including, without limitation, an investigation or partial proceeding, such as a deposition), whether commenced or threatened.

 

“Prospectus” means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated under the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the offering of any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to the Prospectus, including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference in such Prospectus.

 

“Registrable Securities” means:  (i) the shares of Common Stock issued to Investors pursuant to the Purchase Agreement, (ii) the Make Good Shares, as applicable, (iii) any shares of Common Stock issuable upon the exercise of the Warrants issued to the Investors pursuant to the Purchase Agreement, (iv) any shares of Common Stock issuable upon the exercise of warrants issued to any placement agent as compensation in connection with the financing that is the subject of the Purchase Agreement (“Placement Agent Warrant Shares”) and (v) any securities issued or issuable upon any stock split, dividend or other distribution, recapitalization or similar event, or any price adjustment as a result of such stock splits, reverse stock splits or similar events with respect to any of the securities referenced in (i) – (iv) above.  Notwithstanding the foregoing, a security shall cease to be a Registrable Security for purposes of this Agreement from and after such time as the Holder of such security may resell such security without volume restrictions under Rule 144, as determined by the counsel to the Company pursuant to a written opinion letter to such effect, addressed and acceptable to the Company’s transfer agent and the affected Holders.

 

  

3

  

 

“Registration Statement” means the initial registration statement required to be filed in accordance with Section 2(a) and any additional registration statements required to be filed under this Agreement, including in each case the Prospectus, amendments and supplements to such registration statements or Prospectus, including pre- and post- effective amendments, all exhibits thereto, and all material incorporated by reference or deemed to be incorporated by reference therein.

 

“Required Holders” means the Holders of at least a majority of the Registrable Securities or the Investor Representative acting in accordance with the authority granted under Section 2.7 of the Purchase Agreement.

 

“Restriction Termination Date” has the meaning set forth in Section 2(b).

 

“Rule 144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

 

“Rule 415” means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

 

“Rule 424” means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

 

“SEC Restrictions” has the meaning set forth in Section 2(b).

 

“Selling Holder Questionnaire” means the selling security holder notice and questionnaire attached as Annex B hereto.

 

“Trading Market” means any of the New York Stock Exchange, the NYSE AMEX, the NASDAQ Global Select Market, the NASDAQ Global Market, the NASDAQ Capital Market, the OTCBB or any other market on which the Common Stock is listed or quoted for trading on the date in question.

 

  

4

  

 

2.           Registration.

 

(a)           On or prior to the applicable Filing Date, the Company shall prepare and file with the Commission a Registration Statement covering the resale of all Registrable Securities (other than in the case of the initial Registration Statement to be filed under this Section 2(a), the Make Good Shares) not already covered by an existing and effective Registration Statement for an offering to be made on a continuous basis pursuant to Rule 415.  Each Registration Statement required to be filed under this Agreement shall be filed on Form S-1 (or on such other form appropriate for such purpose) and contain (except if otherwise required pursuant to written comments received from the Commission upon a review of such Registration Statement, other than as to the characterization of any Holder as an underwriter, which shall not occur unless such characterization is consistent with written information provided by the Holder in the Selling Holder Questionnaire) the “Plan of Distribution” attached hereto as Annex A.  The Company shall cause each Registration Statement required to be filed under this Agreement to be declared effective under the Securities Act as soon as possible but, in any event, no later than its Effectiveness Date, and shall use its commercially reasonable best efforts to keep each such Registration Statement continuously effective during its entire Effectiveness Period.  By 5:00 p.m. (New York City time) on the Business Day immediately following the Effective Date of each Registration Statement, the Company shall file with the Commission in accordance with Rule 424 under the Securities Act the final prospectus to be used in connection with sales pursuant to such Registration Statement (whether or not such filing is technically required under such Rule).  If for any reason other than due solely to SEC Restrictions, a Registration Statement is effective but not all outstanding Registrable Securities are registered for resale pursuant thereto, then the Company shall prepare and file by the applicable Filing Date an additional Registration Statement to register the resale of all such unregistered Registrable Securities for an offering to be made on a continuous basis pursuant to Rule 415.

 

(b)           Notwithstanding anything to the contrary contained in this Section 2, if the Company receives Commission Comments, and following discussions with and responses to the Commission in which the Company uses its commercially reasonable best efforts and time to cause as many Registrable Securities (other than the Make Good Shares, unless the Make Good Shares Delivery Date shall have occurred) for as many Holders as possible to be included in the Registration Statement filed pursuant to Section 2(a) without characterizing any Holder as an underwriter unless such characterization is consistent with written information provided by the Holder in the Selling Holder Questionnaire (and in such regard uses its commercially reasonable best efforts to cause the Commission to permit the Investor Representative or its counsel to participate in Commission conversations on such issue together with the Company’s counsel, and timely conveys relevant information concerning such issue with the Investor Representative or its counsel) (the day that such discussions and responses are concluded shall be referred to as the “Tolling Date”), the Company is unable to cause the inclusion of all Registrable Securities, then the Company may, following not less than three (3) Trading Days prior written notice to the Investor Representative (i) remove from the Registration Statement such Registrable Securities (the “Cut Back Shares”) and/or (ii) agree to such restrictions and limitations on the registration and resale of the Registrable Securities, in each case as the Commission may require in order for the Commission to allow such Registration Statement to become effective; provided, that in no event may the Company characterize any Holder as an underwriter unless such characterization is consistent with written information provided by the Holder in the Selling Holder Questionnaire (collectively, the “SEC Restrictions”).  Unless the SEC Restrictions otherwise require, any cut-back imposed pursuant to this Section 2(b) shall be allocated:  (i) first, upon the holders of any other securities of the Company who have the right to have such securities included in the Registration Statement, (ii) second, upon the Placement Agent Warrant Shares, and (iii) lastly, among the remaining Registrable Securities of the Holders on a pro rata basis.  No liquidated damages under Section 2(e) shall accrue on or as to any Cut Back Shares, and the required Effectiveness Date for such Registration Statement will be tolled until such time as the Company is able to effect the registration of the Cut Back Shares in accordance with any SEC Restrictions if such Registrable Securities cannot at such time be resold by the Holders thereof without volume limitations pursuant to Rule 144 (such date, the “Restriction Termination Date”).  From and after the Restriction Termination Date, all provisions of this Section 2 shall again be applicable to the Cut Back Shares (which, for avoidance of doubt, retain their character as “Registrable Securities”) if such Registrable Securities cannot at such time be resold by the Holders thereof without volume limitations pursuant to Rule 144 so that the Company will be required to file with and cause to be declared effective by the Commission such additional Registration Statements in the time frames set forth herein as necessary to ultimately cause to be covered by effective Registration Statements all Registrable Securities.  For the avoidance of doubt, the time period starting from the Tolling Date and ending with the Restriction Termination Date shall be excluded in calculating the applicable Effectiveness Date.

 

  

5

  

 

(c)           Promptly following any date on which the Company becomes eligible to use a registration statement on Form S-3 to register Registrable Securities for resale, the Company shall file a Registration Statement on Form S-3 covering all Registrable Securities (or a post-effective amendment on Form S-3 to the then effective Registration Statement) and shall cause such Registration Statement to be filed by the Filing Date for such Registration Statement and declared effective under the Securities Act as soon as possible thereafter, but in any event prior to the Effectiveness Date therefor.  Such Registration Statement shall contain (except if otherwise required pursuant to written comments received from the Commission upon a review of such Registration Statement, other than as to the characterization of any Holder as an underwriter, which shall not occur unless such characterization is consistent with written information provided by the Holder in the Selling Holder Questionnaire) the “Plan of Distribution” attached hereto as Annex A.  The Company shall use its commercially reasonable best efforts to keep such Registration Statement continuously effective under the Securities Act during the entire Effectiveness Period.  By 5:00 p.m. (New York City time) on the Business Day immediately following the Effective Date of such Registration Statement, the Company shall file with the Commission in accordance with Rule 424 under the Securities Act the final prospectus to be used in connection with sales pursuant to such Registration Statement (whether or not such filing is technically required under such Rule).

 

(d)           On or prior to its Filing Date, the Company shall prepare and file with the Commission a Registration Statement covering the resale of the Make Good Shares delivered to Investors in connection with the Make Good Escrow Agreement on Form S-3 if the Company is then eligible to utilize such Form (or if the Company is not then eligible to utilize such form of registration, it shall utilize such other available form appropriate for such purpose) and shall cause such Registration Statement to be filed by the Filing Date for such Registration Statement and declared effective under the Securities Act as soon as possible thereafter, but in any event prior to the Effectiveness Date therefore.  Such Registration Statement shall contain (except if otherwise required pursuant to written comments received from the Commission upon a review of such Registration Statement, other than as to the characterization of any Holder as an underwriter, which shall not occur without such Holder’s consent) the “Plan of Distribution” attached hereto as Annex A.  The Company shall use its commercially reasonable best efforts to keep such Registration Statement continuously effective under the Securities Act during the entire Effectiveness Period which is applicable to it.  By 5:00 p.m. (New York City time) on the Business Day immediately following the Effective Date of such Registration Statement, the Company shall file with the Commission in accordance with Rule 424 under the Securities Act the final prospectus to be used in connection with sales pursuant to such Registration Statement (whether or not such filing is technically required under such Rule).

 

  

6

  

 

(e)           If:  (i) a Registration Statement is not filed on or prior to its Filing Date covering the Registrable Securities required under this Agreement to be included therein), or (ii) a Registration Statement is not declared effective by the Commission on or prior to its required Effectiveness Date or if by the Business Day immediately following the Effective Date the Company shall not have filed a “final” prospectus for the Registration Statement with the Commission under Rule 424(b) (whether or not such a prospectus is technically required by such Rule), or (iii) after its Effective Date, without regard for the reason thereunder or efforts therefore, such Registration Statement ceases for any reason to be effective and available to the Investors as to the Registrable Securities to which it is required to cover at any time prior to the expiration of its Effectiveness Period for more than an aggregate of 30 Trading Days (which need not be consecutive) (any such failure or breach being referred to as an “Event,” and for purposes of clauses (i) or (ii) the date on which such Event occurs, or for purposes of clause (iii) the date which such 30 Trading Day-period is exceeded, being referred to as an “Event Date”), then in addition to any other rights the Investors may have hereunder or under applicable law, on each such Event Date and on each monthly anniversary of each such Event Date (if the applicable Event shall not have been cured by such date) until the applicable Event is cured, the Company shall pay to each Investor an amount in cash, as partial liquidated damages and not as a penalty, equal to 1.0% of the aggregate Investment Amount paid by such Investor pursuant to the Purchase Agreement.  The parties agree that (1) the Company will not be liable for liquidated damages under this Agreement with respect to any (i) Warrants, (ii) Warrant Shares, (iii) warrants issued to any placement agent as compensation in connection with the financing that is the subject of the Purchase Agreement, or (iv) Placement Agent Warrant Shares and (2) in no event will the Company be liable for liquidated damages under this Agreement in excess of 1.0% of the aggregate Investment Amount of the Investors in any single month and the maximum aggregate liquidated damages payable to an Investor under this Agreement shall be ten percent (10%) of the aggregate Investment Amount paid by such Investor pursuant to the Purchase Agreement.  The partial liquidated damages pursuant to the terms hereof shall apply on a daily pro-rata basis for any portion of a month prior to the cure of an Event (except in the case of the first Event Date), and shall cease to accrue (unless earlier cured) upon the expiration of the Effectiveness Period.

 

(f)           Each Holder agrees to furnish to the Company a completed Questionnaire in the form attached to this Agreement as Annex B (a “Selling Holder Questionnaire”).  The Company shall not be required to include the Registrable Securities of a Holder in a Registration Statement and shall not be required to pay any liquidated or other damages under Section 2(e) to any Holder who fails to furnish to the Company a fully completed Selling Holder Questionnaire at least two Trading Days prior to the Filing Date (subject to the requirements set forth in Section 3(a)).

 

3.           Registration Procedures.

 

In connection with the Company’s registration obligations hereunder:

 

  

7

  

 

(a)          The Company shall not file a Registration Statement, any Prospectus or any amendments or supplements thereto in which the “Selling Stockholder” section thereof differs from the disclosure received from a Holder in its Selling Holder Questionnaire (as amended or supplemented).  The Company shall not file a Registration Statement, any Prospectus or any amendments or supplements thereto in which it (i) characterizes any Holder as an underwriter, unless such characterization is consistent with written information provided by the Holder in the Selling Holder Questionnaire, or (ii) reduces the number of Registrable Securities being registered on behalf of a Holder except pursuant to, in the case of subsection (iii), the Commission Comments, without, in each case, such Holder’s express written authorization, unless such reduction is made pursuant to Section 2(b) hereof.  The Company shall also ensure that each Registration Statement (including any amendments or supplements thereto and prospectuses contained therein) shall not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein, or necessary to make the statements therein (in the case of prospectuses, in the light of the circumstances in which they were made) not misleading.

 

(b)          The Company shall (i) prepare and file with the Commission such amendments, including post-effective amendments, to each Registration Statement and the Prospectus used in connection therewith as may be necessary to keep such Registration Statement continuously effective as to the applicable Registrable Securities for its Effectiveness Period and prepare and file with the Commission such additional Registration Statements in order to register for resale under the Securities Act all of the Registrable Securities; (ii) cause the related Prospectus to be amended or supplemented by any required Prospectus supplement, and as so supplemented or amended to be filed pursuant to Rule 424; (iii) respond as promptly as reasonably possible to any comments received from the Commission with respect to each Registration Statement or any amendment thereto and, as promptly as reasonably possible provide the Investor Representative true and complete copies of all correspondence from and to the Commission relating to such Registration Statement that would not result in the disclosure to the Investor Representative of material and non-public information concerning the Company; and (iv) comply in all material respects with the provisions of the Securities Act and the Exchange Act with respect to the Registration Statement(s) and the disposition of all Registrable Securities covered by each Registration Statement.

 

(c)          The Company shall notify the Investor Representative as promptly as reasonably possible (and, in the case of (i)(A) below, not less than three Trading Days prior to such filing and, in the case of (v) below, not less than three Trading Days prior to the financial statements in any Registration Statement becoming ineligible for inclusion therein) and (if requested by any such Person) confirm such notice in writing no later than one Trading Day following the day (i)(A) when a Prospectus or any Prospectus supplement or post-effective amendment to a Registration Statement is proposed to be filed; (B) when the Commission notifies the Company whether there will be a “review” of such Registration Statement and whenever the Commission comments in writing on such Registration Statement (the Company shall provide true and complete copies thereof and all written responses thereto to the Investor Representative pertain to the Holders as a Selling Stockholder or to the Plan of Distribution, but not information which the Company believes would constitute material and non-public information); and (C) with respect to each Registration Statement or any post-effective amendment, when the same has become effective; (ii) of any request by the Commission or any other Federal or state governmental authority for amendments or supplements to a Registration Statement or Prospectus or for additional information; (iii) of the issuance by the Commission of any stop order suspending the effectiveness of a Registration Statement covering any or all of the Registrable Securities or the initiation of any Proceedings for that purpose; (iv) of the receipt by the Company of any notification with respect to the suspension of the qualification or exemption from qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation or threatening of any Proceeding for such purpose; and (v) of the occurrence of any event or passage of time that makes the financial statements included in a Registration Statement ineligible for inclusion therein or any statement made in such Registration Statement or Prospectus or any document incorporated or deemed to be incorporated therein by reference untrue in any material respect or that requires any revisions to such Registration Statement, Prospectus or other documents so that, in the case of such Registration Statement or the Prospectus, as the case may be, it will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading.

 

  

8

  

 

(d)          The Company shall use its commercially reasonable best efforts to prevent the issuance of any stop order or other suspension of effectiveness of a Registration Statement, or the suspension of the qualification of any of the Registrable Securities for sale in any jurisdiction and, if such an order or suspension is issued, to obtain the withdrawal of such order or suspension at the earliest possible moment and to notify the Investor Representative of the issuance of such order and the resolution thereof or its receipt of actual notice of the initiation or threat of any proceeding for such purpose.

 

(e)          The Company shall furnish to the Investor Representative, without charge and at the option of the Company in electronic format, at least one conformed copy of each Registration Statement and each amendment thereto and all exhibits to the extent requested by the Investor Representative (including those previously furnished) promptly after the filing of such documents with the Commission.

 

(f)           The Company shall promptly deliver to the Investor Representative, without charge, as many copies of each Prospectus or Prospectuses (including each form of prospectus) and each amendment or supplement thereto as the Investor Representative may reasonably request.  The Company hereby consents to the use of such Prospectus and each amendment or supplement thereto by each of the selling Holders in connection with the offering and sale of the Registrable Securities covered by such Prospectus and any amendment or supplement thereto.

 

(g)          Prior to any public offering of Registrable Securities, the Company shall register or qualify such Registrable Securities for offer and sale under the securities or Blue Sky laws of all jurisdictions within the United States as any Holder may request, to keep each such registration or qualification (or exemption therefrom) effective during the Effectiveness Period and to do any and all other acts or things necessary or advisable to enable the disposition in such jurisdictions of the Registrable Securities covered by the Registration Statements; provided, however, in connection with any such registration or qualification, the Company shall not be required to (i) qualify to do business in any jurisdiction where the Company would not otherwise be required to qualify, (ii) subject itself to general taxation in any such jurisdiction, (iii) file a general consent to service of process in any jurisdiction, or (iv) make any change to the Company’s certificate of incorporation or bylaws.

 

  

9

  

 

(h)          The Company shall cooperate with the Holders to facilitate the timely preparation and delivery of certificates representing Registrable Securities to be delivered to a transferee pursuant to the Registration Statement(s), which certificates shall be free, to the extent permitted by the Purchase Agreement, of all restrictive legends, and to enable such Registrable Securities to be in such denominations and registered in such names as any such Holders may request.

 

(i)           Upon the occurrence of any event contemplated by Section 3(c)(v), as promptly as reasonably possible, the Company shall prepare a supplement or amendment, including a post-effective amendment, to the affected Registration Statements or a supplement to the related Prospectus or any document incorporated or deemed to be incorporated therein by reference, and file any other required document so that, as thereafter delivered, no Registration Statement nor any Prospectus will contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading.

 

(j)           The Company shall notify the Investor Representative in writing of the happening of any event, as promptly as practicable after becoming aware of such event, as a result of which the prospectus included in a Registration Statement, as then in effect, includes an untrue statement of a material fact or omission to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading (provided that in no event shall such notice contain any material, nonpublic information), and promptly prepare a supplement or amendment to such Registration Statement to correct such untrue statement or omission.  The Company shall also promptly notify the Investor Representative in writing when a prospectus or any prospectus supplement or post-effective amendment has been filed, and when a Registration Statement or any post-effective amendment has become effective.

 

(k)          If any Holder is required under applicable securities laws to be described in the Registration Statement as an underwriter, at the reasonable request of such Holder, the Company shall furnish to such Holder, on the date of the effectiveness of the Registration Statement and thereafter from time to time on such dates as a Holder may reasonably request:  (i) a letter, dated such date, from the Company’s independent certified public accountants in form and substance as is customarily given by independent certified public accountants to underwriters in an underwritten public offering, addressed to the Holders, and (ii) an opinion, dated as of such date, of counsel representing the Company for purposes of such Registration Statement, in form, scope and substance reasonably acceptable to such counsel and as is customarily given in an underwritten public offering, addressed to the Holders.

 

(l)           The Company shall hold in confidence and not make any disclosure of information concerning a Holder provided to the Company unless:  (i) disclosure of such information is necessary to comply with federal or state securities laws, (ii) the disclosure of such information is necessary to avoid or correct a misstatement or omission in any Registration Statement, (iii) the release of such information is ordered pursuant to a subpoena or other final, non-appealable order from a court or governmental body of competent jurisdiction, or (iv) such information has been made generally available to the public other than by disclosure in violation of this Agreement or any other agreement.  The Company agrees that it shall, upon learning that disclosure of such information concerning a Holder is sought in or by a court or governmental body of competent jurisdiction or through other means, give prompt written notice to such Holder or the Investor Representative and allow such Holder, at the Holder’s expense, to undertake appropriate action to prevent disclosure of, or to obtain a protective order for, such information.

 

  

10

  

 

(m)         The Company shall use its commercially reasonable best efforts to cause all of the Registrable Securities covered by a Registration Statement to be listed on each national securities exchange on which securities of the same class or series issued by the Company are then listed, if any, if the listing of such Registrable Securities is then permitted under the rules of such exchange.  The Company shall pay all fees and expenses in connection with satisfying its obligation under this Section 3(m).

 

(n)          The Company shall cooperate with the Holders who hold Registrable Securities being offered and, to the extent applicable, facilitate the timely preparation and delivery of certificates (not bearing any restrictive legend to the extent permitted by the Purchase Agreement) representing the Registrable Securities to be offered pursuant to a Registration Statement and enable such certificates to be in such denominations or amounts, as the case may be, as the Holders may reasonably request and registered in such names as the Holders may request.

 

(o)          If requested by a Holder, the Company shall as soon as practicable:  (i) incorporate in a prospectus supplement or post-effective amendment such information as a Holder reasonably requests to be included therein relating to the sale and distribution of Registrable Securities, including, without limitation, information with respect to the number of Registrable Securities being offered or sold, the purchase price being paid therefor and any other terms of the offering of the Registrable Securities to be sold in such offering; (ii) make all required filings of such prospectus supplement or post-effective amendment after being notified of the matters to be incorporated in such prospectus supplement or post-effective amendment; and (iii) supplement or make amendments to any Registration Statement if reasonably requested by a Holder holding any Registrable Securities.

 

(p)          The Company shall use its commercially reasonable best efforts to cause the Registrable Securities covered by a Registration Statement to be registered with or approved by such other governmental agencies or authorities as may be necessary to consummate the disposition of such Registrable Securities.

 

  

11

  

 

4.           Registration Expenses.  All fees and expenses incident to the performance of or compliance with this Agreement by the Company shall be borne by the Company whether or not any Registrable Securities are sold pursuant to a Registration Statement.  The fees and expenses referred to in the foregoing sentence shall include, without limitation, (i) all registration and filing fees (including, without limitation, fees and expenses (A) with respect to filings required to be made with any Trading Market on which the Common Stock is then listed for trading, (B) with respect to filings with FINRA by the Investor Representative’s counsel for compensation review pursuant to FINRA Rule 5110, but in no event shall the sum of such fees and expenses and other transaction costs and legal fees incurred by the Investor Representative to be reimbursed by the Company in connection with such FINRA filing be more than $15,000, and (C) in compliance with applicable state securities or Blue Sky laws), (ii) printing expenses (including, without limitation, expenses of printing certificates for Registrable Securities and of printing prospectuses if the printing of prospectuses is reasonably requested by the Investor Representative), (iii) messenger, telephone and delivery expenses, (iv) fees and disbursements of counsel for the Company, (v) Securities Act liability insurance, if the Company so desires such insurance, and (vi) fees and expenses of all other Persons retained by the Company in connection with the consummation of the transactions contemplated by this Agreement.  In addition, the Company shall be responsible for all of its internal expenses incurred in connection with the consummation of the transactions contemplated by this Agreement (including, without limitation, all salaries and expenses of its officers and employees performing legal or accounting duties), the expense of any annual audit and the fees and expenses incurred in connection with the listing of the Registrable Securities on any securities exchange as required hereunder.  In no event shall the Company be responsible for any broker or similar commissions incurred by any Holder or, except to the extent provided for in the Transaction Documents, any legal fees or other cost of the Holders in connection with this Agreement.

 

5.           Indemnification.

 

  (a)           Indemnification by the Company.  The Company shall, notwithstanding any termination of this Agreement, indemnify and hold harmless each Holder, the officers, directors, agents, investment advisors, partners, members and employees of each of them, each Person who controls any such Holder (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) and the officers, directors, agents and employees of each such controlling Person, to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities, costs (including, without limitation, reasonable costs of preparation and reasonable attorneys’ fees) and expenses (collectively, “Losses”), as incurred, arising out of or relating to any untrue or alleged untrue statement of a material fact contained in any Registration Statement, any Prospectus or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus or form of prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading, except to the extent, but only to the extent, that (1) such untrue statements or omissions are based solely upon information regarding such Holder furnished in writing to the Company by such Holder expressly for use therein, or to the extent that such information relates to such Holder or such Holder’s proposed method of distribution of Registrable Securities and was reviewed and expressly approved in writing by such Holder expressly for use in the Registration Statement, such Prospectus or such form of Prospectus or in any amendment or supplement thereto (it being understood that the Holder has approved Annex A hereto for this purpose) or (2) in the case of an occurrence of an event of the type specified in Section 3(c)(ii)-(v), the use by such Holder of an outdated or defective Prospectus after the Company has notified the Investor Representative in writing that the Prospectus is outdated or defective and prior to the receipt by such Holder of an Advice or an amended or supplemented Prospectus, but only if and to the extent that following the receipt of the Advice or the amended or supplemented Prospectus the misstatement or omission giving rise to such Loss would have been corrected.  The Company shall notify the Investor Representative promptly of the institution, threat or assertion of any Proceeding of which the Company is aware in connection with the transactions contemplated by this Agreement.

 

  

12

  

 

(b)           Indemnification by Holders.  Each Holder shall, severally and not jointly, indemnify and hold harmless the Company, its directors, officers, agents and employees, each Person who controls the Company (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, agents or employees of such controlling Persons, to the fullest extent permitted by applicable law, from and against all Losses, as incurred, arising solely out of or based solely upon:  (x) such Holder’s failure to comply with the prospectus delivery requirements of the Securities Act or (y) any untrue statement of a material fact contained in any Registration Statement, any Prospectus, or any form of prospectus, or in any amendment or supplement thereto, or arising solely out of or based solely upon any omission of a material fact required to be stated therein or necessary to make the statements therein not misleading to the extent, but only to the extent that, (1) such untrue statements or omissions are based solely upon information regarding such Holder furnished in writing to the Company by such Holder expressly for use therein, or to the extent that such information relates to such Holder or such Holder’s proposed method of distribution of Registrable Securities and was reviewed and expressly approved in writing by such Holder expressly for use in the Registration Statement (it being understood that the Holder has approved Annex A hereto for this purpose), such Prospectus or such form of Prospectus or in any amendment or supplement thereto or (2) in the case of an occurrence of an event of the type specified in Section 3(c)(ii)-(v), the use by such Holder of an outdated or defective Prospectus after the Company has notified such Holder in writing that the Prospectus is outdated or defective and prior to the receipt by such Holder of an Advice or an amended or supplemented Prospectus, but only if and to the extent that following the receipt of the Advice or the amended or supplemented Prospectus the misstatement or omission giving rise to such Loss would have been corrected.  In no event shall the liability of any selling Holder hereunder be greater in amount than the dollar amount of the net proceeds received by such Holder upon the sale of the Registrable Securities giving rise to such indemnification obligation.

 

(c)           Conduct of Indemnification Proceedings.  If any Proceeding shall be brought or asserted against any Person entitled to indemnity hereunder (an “Indemnified Party”), such Indemnified Party shall promptly notify the Person from whom indemnity is sought (the “Indemnifying Party”) in writing, and the Indemnifying Party shall assume the defense thereof, including the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of all fees and expenses incurred in connection with defense thereof; provided, that the failure of any Indemnified Party to give such notice shall not relieve the Indemnifying Party of its obligations or liabilities pursuant to this Agreement, except (and only) to the extent that it shall be finally determined by a court of competent jurisdiction (which determination is not subject to appeal or further review) that such failure shall have proximately and materially adversely prejudiced the Indemnifying Party.

 

An Indemnified Party shall have the right to employ separate counsel in any such Proceeding and to participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Indemnified Party or Parties unless:  (1) the Indemnifying Party has agreed in writing to pay such fees and expenses; (2) the Indemnifying Party shall have failed promptly to assume the defense of such Proceeding and to employ counsel reasonably satisfactory to such Indemnified Party in any such Proceeding; or (3) the named parties to any such Proceeding (including any impleaded parties) include both such Indemnified Party and the Indemnifying Party, and such Indemnified Party shall have been advised by counsel that a conflict of interest is likely to exist if the same counsel were to represent such Indemnified Party and the Indemnifying Party (in which case, if such Indemnified Party notifies the Indemnifying Party in writing that it elects to employ separate counsel at the expense of the Indemnifying Party, the Indemnifying Party shall not have the right to assume the defense thereof and such counsel shall be at the expense of the Indemnifying Party); provided, that, the Indemnifying Party shall pay for no more than two separate sets of counsel for all Indemnified Parties and such legal counsel shall be selected by the Investor Representative.  The Indemnifying Party shall not be liable for any settlement of any such Proceeding effected without its written consent, which consent shall not be unreasonably withheld.  No Indemnifying Party shall, without the prior written consent of the Indemnified Party, effect any settlement of any pending Proceeding in respect of which any Indemnified Party is a party, unless such settlement includes an unconditional release of such Indemnified Party from all liability on claims that are the subject matter of such Proceeding.

 

  

13

  

 

All fees and expenses of the Indemnified Party (including reasonable fees and expenses to the extent incurred in connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section) shall be paid to the Indemnified Party, as incurred, within ten Trading Days of written notice thereof to the Indemnifying Party (regardless of whether it is ultimately determined that an Indemnified Party is not entitled to indemnification hereunder; provided, that the Indemnifying Party may require such Indemnified Party to undertake to reimburse all such fees and expenses to the extent it is finally judicially determined that such Indemnified Party is not entitled to indemnification hereunder).

 

(d)           Contribution.  If a claim for indemnification under Section 5(a) or 5(b) is unavailable to an Indemnified Party (by reason of public policy or otherwise), then each Indemnifying Party, in lieu of indemnifying such Indemnified Party, shall contribute to the amount paid or payable by such Indemnified Party as a result of such Losses, in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified Party in connection with the actions, statements or omissions that resulted in such Losses as well as any other relevant equitable considerations.  The relative fault of such Indemnifying Party and Indemnified Party shall be determined by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission of a material fact, has been taken or made by, or relates to information supplied by, such Indemnifying Party or Indemnified Party, and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such action, statement or omission.  The amount paid or payable by a party as a result of any Losses shall be deemed to include, subject to the limitations set forth in Section 5(c), any reasonable attorneys’ or other reasonable fees or expenses incurred by such party in connection with any Proceeding to the extent such party would have been indemnified for such fees or expenses if the indemnification provided for in this Section was available to such party in accordance with its terms.

 

The parties hereto agree that it would not be just and equitable if contribution pursuant to this Section 5(d) were determined by pro rata allocation or by any other method of allocation that does not take into account the equitable considerations referred to in the immediately preceding paragraph.  Notwithstanding the provisions of this Section 5(d), (i) no Person involved in the sale of Registrable Securities which Person is guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) in connection with such sale shall be entitled to contribution from any Person involved in such sale of Registrable Securities who was not guilty of fraudulent misrepresentation; and (ii) no Holder shall be required to contribute, in the aggregate, any amount in excess of the amount by which the proceeds actually received by such Holder from the sale of the Registrable Securities subject to the Proceeding exceeds the amount of any damages that such Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission.

 

  

14

  

 

The indemnity and contribution agreements contained in this Section are in addition to any liability that the Indemnifying Parties may have to the Indemnified Parties.

 

6.           Reports Under the Exchange Act.  With a view to making available to the Holders the benefits of Rule 144 or any other similar rule or regulation of the SEC that may at any time permit the Holders to sell Registrable Securities of the Company to the public without registration, the Company agrees, for so long as Registrable Securities are outstanding and held by the Holders, to:

 

(a)           make and keep public information available, as those terms are understood, defined and required in Rule 144;

 

(b)           file with the SEC in a timely manner all reports and other documents required of the Company under the Securities Act and the Exchange Act so long as the Company remains subject to such requirements and the filing of such reports and other documents is required for the applicable provisions of Rule 144; and

 

(c)           furnish to each Holder so long as such Holder owns Registrable Securities, promptly upon request, such information as may be reasonably and customarily requested to permit the Holders to sell such securities pursuant to Rule 144 without registration.

 

7.           Assignment of Registration Rights.  The rights under this Agreement shall be automatically assignable by the Investors to any permitted transferee of all or any portion of such Investor’s Registrable Securities if:  (i) the Investor agrees in writing with the transferee or assignee to assign such rights, and a copy of such agreement is furnished to the Company within five (5) Business Days after such assignment; (ii) the Company is, within five (5) Business Days after such transfer or assignment, furnished with written notice of (a) the name and address of such transferee or assignee, and (b) the securities with respect to which such registration rights are being transferred or assigned; (iii) immediately following such transfer or assignment the further disposition of such securities by the transferee or assignee is restricted under the Securities Act or applicable state securities laws; (iv) at or before the time the Company receives the written notice contemplated by clause (ii) of this sentence the transferee or assignee agrees in writing with the Company to be bound by all of the provisions contained herein; and (v) such transfer shall have been made in accordance with the applicable requirements of the Purchase Agreement.

 

  

15

  

 

8.           Miscellaneous.

 

  (a)         Third Party Beneficiary.  The Investor Representative is an intended third party beneficiary of this Agreement and shall have all of the rights of an “Investor” under this Agreement and the Placement Agent Warrant Shares (and any capital stock of the Company issued or issuable, with respect to the warrants issued to the Placement Agent as a result of any stock split, stock dividend, recapitalization, exchange, anti-dilution adjustment or similar event or otherwise, without regard to any limitations on exercises of the warrants, if any) constitute Registrable Securities for all purposes of this Agreement.

 

  (b)        Remedies.  In the event of a breach by the Company or by a Holder, of any of their obligations under this Agreement, each Holder or the Company, as the case may be, in addition to being entitled to exercise all rights granted by law and under this Agreement, including recovery of damages, will be entitled to specific performance of its rights under this Agreement.  The Company and each Holder agree that monetary damages would not provide adequate compensation for any losses incurred by reason of a breach by it of any of the provisions of this Agreement and hereby further agree that, in the event of any action for specific performance in respect of such breach, each shall waive the defense that a remedy at law would be adequate.

 

  (c)        Compliance.  Each Holder covenants and agrees that it will comply with the prospectus delivery requirements of the Securities Act as applicable to it in connection with sales of Registrable Securities pursuant to the Registration Statement.

 

  (d)        Discontinued Disposition.  Each Holder agrees by its acquisition of such Registrable Securities that, upon receipt of a notice from the Company of the occurrence of any event of the kind described in Section 3(c), such Holder will forthwith discontinue disposition of such Registrable Securities under the Registration Statement until such Holder’s receipt of the copies of the supplemented Prospectus and/or amended Registration Statement or until it is advised in writing (the “Advice”) by the Company that the use of the applicable Prospectus may be resumed, and, in either case, has received copies of any additional or supplemental filings that are incorporated or deemed to be incorporated by reference in such Prospectus or Registration Statement.  The Company may provide appropriate stop orders to enforce the provisions of this paragraph.

 

  (e)        Piggy-Back Registrations.  If at any time during the Effectiveness Period there is not an effective Registration Statement covering all of the Registrable Securities and the Company shall determine to prepare and file with the Commission a registration statement relating to an offering for its own account or the account of others under the Securities Act of any of its equity securities, other than on Form S-4 or Form S-8 (each as promulgated under the Securities Act) or their then equivalents relating to equity securities to be issued solely in connection with any acquisition of any entity or business or equity securities issuable in connection with stock option or other employee benefit plans, then the Company shall send to each Holder written notice of such determination and, if within fifteen calendar days after receipt of such notice, any such Holder shall so request in writing, the Company shall include in such registration statement all or any part of such Registrable Securities such holder requests to be registered, subject to customary underwriter cutbacks applicable to all holders of registration rights.

 

  

16

  

 

  (f)         Amendments and Waivers.  Provisions of this Agreement may be amended and the observance thereof may be waived (either generally or in a particular instance and either retroactively or prospectively), only with the written consent of the Company and the Required Holders.  Any amendment or waiver effected in accordance with this Section 8(g) shall be binding upon each Investor and the Company.  No such amendment shall be effective to the extent that it applies to less than all of the Holders.  No consideration shall be offered or paid to any Person to amend or consent to a waiver or modification of any provision of this Agreement unless the same consideration also is offered to all of the parties to this Agreement.  Notwithstanding the foregoing, a waiver or consent to depart from the provisions hereof with respect to a matter that relates exclusively to the rights of certain Holders and that does not directly or indirectly affect the rights of other Holders may be given by Holders of at least a majority of the Registrable Securities to which such waiver or consent relates.

 

  (g)        Notices.  Any notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement must be in writing and will be deemed to have been delivered if delivered in accordance with Section 6.3 of the Purchase Agreement.

 

  (h)        Successors and Assigns.  This Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns of each of the parties and shall inure to the benefit of each Holder.  The Company may not assign its rights or obligations hereunder without the prior written consent of each Holder.  Each Holder may assign their respective rights hereunder in the manner and to the Persons as permitted hereunder and under the Purchase Agreement.

 

  (i)         Execution and Counterparts.  This Agreement may be executed in any number of counterparts, each of which when so executed shall be deemed to be an original and, all of which taken together shall constitute one and the same Agreement.  In the event that any signature is delivered by facsimile or email transmission, such signature shall create a valid binding obligation of the party executing (or on whose behalf such signature is executed) the same with the same force and effect as if such facsimile or email signature were the original thereof.

 

  (j)         Governing Law.  All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof.  Each party agrees that all Proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Agreement (whether brought against a party hereto or its respective Affiliates, employees or agents) will be commenced in the New York Courts.  Each party hereto hereby irrevocably submits to the exclusive jurisdiction of the New York Courts for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any Proceeding, any claim that it is not personally subject to the jurisdiction of any New York Court, or that such Proceeding has been commenced in an improper or inconvenient forum.  Each party hereto hereby irrevocably waives personal service of process and consents to process being served in any such Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof.  Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law.  Each party hereto hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any Proceeding arising out of or relating to this Agreement or the transactions contemplated hereby.  If either party shall commence a Proceeding to enforce any provisions of this Agreement, then the prevailing party in such Proceeding shall be reimbursed by the other party for its attorney’s fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Proceeding.

 

  

17

  

 

  (k)        Cumulative Remedies.  The remedies provided herein are cumulative and not exclusive of any remedies provided by law.

 

  (l)         Entire Agreement.  This Agreement, the other Transaction Documents (as defined in the Purchase Agreement) and the instruments referenced herein and therein constitute the entire agreement among the parties hereto with respect to the subject matter hereof and thereof.  There are no restrictions, promises, warranties or undertakings, other than those set forth or referred to herein and therein.  This Agreement, the other Transaction Documents and the instruments referenced herein and therein supersede all prior agreements and understandings among the parties hereto with respect to the subject matter hereof and thereof.

 

  (m)       Severability.  If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction.  It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.

 

  (n)        Headings.  The headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof.

 

 

 

 

  

18

  

 

  (o)        Independent Nature of Holders’ Obligations and Rights.  The obligations of each Holder under this Agreement are several and not joint with the obligations of each other Holder, and no Holder shall be responsible in any way for the performance of the obligations of any other Holder under this Agreement.  Nothing contained herein or in any Transaction Document, and no action taken by any Holder pursuant thereto, shall be deemed to constitute the Holders as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Holders are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by this Agreement or any other Transaction Document.  Each Holder acknowledges that no other Holder will be acting as agent of such Holder in enforcing its rights under this Agreement.  Each Holder shall be entitled to independently protect and enforce its rights, including without limitation the rights arising out of this Agreement, and it shall not be necessary for any other Holder to be joined as an additional party in any Proceeding for such purpose.  The Company acknowledges that each of the Holders has been provided with the same Registration Rights Agreement for the purpose of closing a transaction with multiple Holders and not because it was required or requested to do so by any Holder.

 

[Signature Page Follows]

 

 

 

 

 

 

 

  

19

  

 

IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the date first written above.

 

	 	COMPANY:
	 	 
	 	U.S. CHINA MINING GROUP, INC.
	 	 
	 	 
	 	 
	 	
By:

	 	 
	 	 	
Name:

	 	 	
Title:

	 	 
	 	INVESTOR REPRESENTATIVE
	 	 
	 	EURO PACIFIC CAPITAL, INC.
	 	 
	 	 
	 	
By:

	 	 
	 	 	
Name:

	 	 	
Title:

	 	 
	 	INVESTORS:
	 	 
	 	
The Investors executing the Signature Page in the form attached hereto as Annex C and delivering the same to the Company or its agents shall be deemed to have executed this Agreement and agreed to the terms hereof.

 

  

  

  

 

Annex A

 

Plan of Distribution

 

The Selling Stockholders and any of their pledgees, donees, transferees, assignees and successors-in-interest may, from time to time, sell any or all of their shares of Common Stock on any stock exchange, market or trading facility on which the shares are traded or quoted or in private transactions.  These sales may be at fixed or negotiated prices.  The Selling Stockholders may use any one or more of the following methods when selling shares:

 

	
  

	
·

	
ordinary brokerage transactions and transactions in which the broker-dealer solicits Investors;

 

	
  

	
·

	
block trades in which the broker-dealer will attempt to sell the shares as agent but may position and resell a portion of the block as principal to facilitate the transaction;

 

	
  

	
·

	
purchases by a broker-dealer as principal and resale by the broker-dealer for its account;

 

	
  

	
·

	
an exchange distribution in accordance with the rules of the applicable exchange;

 

	
  

	
·

	
privately negotiated transactions;

 

	
  

	
·

	
through the writing of options on the shares;

 

	
  

	
·

	
to cover short sales made after the date that this Registration Statement is declared effective by the Commission;

 

	
  

	
·

	
broker-dealers may agree with the Selling Stockholders to sell a specified number of such shares at a stipulated price per share; and

 

	
  

	
·

	
a combination of any such methods of sale.

 

The selling stockholders may also sell shares under Rule 144 of the Securities Act of 1933, as amended (the “Securities Act”), if available, rather than under this prospectus.  The selling stockholders shall have the sole and absolute discretion not to accept any purchase offer or make any sale of shares if it deems the purchase price to be unsatisfactory at any particular time.

 

The selling stockholders or their respective pledgees, donees, transferees or other successors in interest, may also sell the shares directly to market makers acting as principals and/or broker-dealers acting as agents for themselves or their customers.  Such broker-dealers may receive compensation in the form of discounts, concessions or commissions from the selling stockholders and/or the purchasers of shares for whom such broker-dealers may act as agents or to whom they sell as principal or both, which compensation as to a particular broker-dealer might be in excess of customary commissions.  Market makers and block purchasers purchasing the shares will do so for their own account and at their own risk.  It is possible that a selling stockholder will attempt to sell shares of common stock in block transactions to market makers or other purchasers at a price per share which may be below the then existing market price.  We cannot assure that all or any of the shares offered in this prospectus will be issued to, or sold by, the selling stockholders.  The selling stockholders and any brokers, dealers or agents, upon effecting the sale of any of the shares offered in this prospectus, may be deemed to be “underwriters” as that term is defined under the Securities Act, the Exchange Act and the rules and regulations of such acts.  In such event, any commissions received by such broker-dealers or agents and any profit on the resale of the shares purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act.

 

  

  

  

 

We are required to pay all fees and expenses incident to the registration of the shares, including fees and disbursements of counsel to the selling stockholders, but excluding brokerage commissions or underwriter discounts.

 

The selling stockholders, alternatively, may sell all or any part of the shares offered in this prospectus through an underwriter.  The selling stockholders have not entered into any agreement with a prospective underwriter and there is no assurance that any such agreement will be entered into.

 

The selling stockholders may pledge their shares to their brokers under the margin provisions of customer agreements.  If a selling stockholder defaults on a margin loan, the broker may, from time to time, offer and sell the pledged shares.  The selling stockholders and any other persons participating in the sale or distribution of the shares will be subject to applicable provisions of the Exchange Act, and the rules and regulations under such act, including, without limitation, Regulation M.  These provisions may restrict certain activities of, and limit the timing of purchases and sales of any of the shares by, the selling stockholders or any other such person.  In the event that any of the selling stockholders are deemed an affiliated purchaser or distribution participant within the meaning of Regulation M, then the selling stockholders will not be permitted to engage in short sales of common stock.  Furthermore, under Regulation M, persons engaged in a distribution of securities are prohibited from simultaneously engaging in market making and certain other activities with respect to such securities for a specified period of time prior to the commencement of such distributions, subject to specified exceptions or exemptions.  In addition, if a short sale is deemed to be a stabilizing activity, then the selling stockholders will not be permitted to engage in a short sale of our common stock.  All of these limitations may affect the marketability of the shares.

 

If a selling stockholder notifies us that it has a material arrangement with a broker-dealer for the resale of the common stock, then we would be required to amend the registration statement of which this prospectus is a part, and file a prospectus supplement to describe the agreements between the selling stockholder and the broker-dealer.

 

  

  

  

 

Annex B

 

U.S. CHINA MINING GROUP, INC.

 

Selling Securityholder Notice and Questionnaire

 

The undersigned beneficial owner of common stock (the “Common Stock”), of U.S. China Mining Group, Inc., a Nevada corporation (the “Company”), understands that the Company has filed or intends to file with the Securities and Exchange Commission (the “Commission”) a Registration Statement for the registration and resale of the Registrable Securities, in accordance with the terms of the Registration Rights Agreement, dated as of January 7, 2011 (the “Registration Rights Agreement”), among the Company and the Investors named therein.  A copy of the Registration Rights Agreement is available from the Company upon request at the address set forth below.  All capitalized terms used and not otherwise defined herein shall have the meanings ascribed thereto in the Registration Rights Agreement.

 

The undersigned hereby provides the following information to the Company and represents and warrants that such information is accurate:

 

QUESTIONNAIRE

 

	
1.

	
Name.

 

	
  

	
(a)

	
Full Legal Name of Selling Securityholder

 

	
  

	 

 

	
  

	
(b)

	
Full Legal Name of Registered Holder (if not the same as (a) above) through which Registrable Securities Listed in Item 3 below are held:

 

	
  

	 

 

	
  

	
(c)

	
Full Legal Name of Natural Control Person (which means a natural person who directly or indirectly alone or with others has power to vote or dispose of the securities covered by the questionnaire):

 

	
  

	 

 

	
2.

	
Address for Notices to Selling Securityholder:

 

	 

	 

	 

	
Telephone:

	 

	
Fax:

	 

	
Contact Person: 

	 

 

  

  

  

 

	
3.

	
Beneficial Ownership of Registrable Securities:

 

Type and Principal Amount of Registrable Securities beneficially owned:

 

 

	 	 
	 	 
	 	 

 

	
4.

	
Broker-Dealer Status:

 

	
  

	
(a)

	
Are you a broker-dealer?

 

	 	Yes   o	No   o

                                               

	
  

	
Note:

	
If yes, the Commission’s staff has indicated that you should be identified as an underwriter in the Registration Statement.

 

	
  

	
(b)

	
Are you an affiliate of a broker-dealer?

 

	 	Yes   o	No   o

 

	
  

	
(c)

	
If you are an affiliate of a broker-dealer, do you certify that you bought the Registrable Securities in the ordinary course of business, and at the time of the purchase of the Registrable Securities to be resold, you had no agreements or understandings, directly or indirectly, with any person to distribute the Registrable Securities?

 

	 	Yes   o	No   o

 

	
  

	
Note:

	
If no, the Commission’s staff has indicated that you should be identified as an underwriter in the Registration Statement.

 

	
5.

	
Beneficial Ownership of Other Securities of the Company Owned by the Selling Securityholder.

 

Except as set forth below in this Item 5, the undersigned is not the beneficial or registered owner of any securities of the Company other than the Registrable Securities listed above in Item 3.

 

	 	Type and Amount of Other Securities beneficially owned by the Selling Securityholder:
	 	 
	 	 
	 	 

 

  

  

  

	
6.

	
Relationships with the Company:

 

Except as set forth below, neither the undersigned nor any of its affiliates, officers, directors or principal equity holders (owners of 5% of more of the equity securities of the undersigned) has held any position or office or has had any other material relationship with the Company (or its predecessors or affiliates) during the past three years.

 

	 	State any exceptions here:
	 	 
	 	 
	 	 

 

7.           The Company has advised each Selling Stockholder that it is the view of the Commission that it may not use shares registered on the Registration Statement to cover short sales of Common Stock made prior to the date on which the Registration Statement is declared effective by the Commission, in accordance with 1997 Securities and Exchange Commission Manual of Publicly Available Telephone Interpretations Section A.65.  If a Selling Stockholder uses the prospectus for any sale of the Common Stock, it will be subject to the prospectus delivery requirements of the Securities Act.  The Selling Stockholders will be responsible to comply with the applicable provisions of the Securities Act and Exchange Act, and the rules and regulations thereunder promulgated, including, without limitation, Regulation M, as applicable to such Selling Stockholders in connection with resales of their respective shares under the Registration Statement.

 

The undersigned agrees to promptly notify the Company of any inaccuracies or changes in the information provided herein that may occur subsequent to the date hereof and prior to the Effective Date for the Registration Statement.

 

Certain legal consequences arise from being named as a Selling Securityholder in the Registration Statement and related prospectus.  Accordingly, the undersigned is advised to consult their own securities law counsel regarding the consequence of being named or not being named as a Selling Securityholder in the Registration Statement and the related prospectus.

 

By signing below, the undersigned consents to the disclosure of the information contained herein in its answers to Items 1 through 6 and the inclusion of such information in the Registration Statement and the related prospectus.  The undersigned understands that such information will be relied upon by the Company in connection with the preparation or amendment of the Registration Statement and the related prospectus.  The undersigned hereby elects to include the Registrable Securities owned by it and listed above in Item 3 (unless otherwise specified in Item 3) in the Registration Statement.

 

  

  

  

 

IN WITNESS WHEREOF the undersigned, by authority duly given, has caused this Notice and Questionnaire to be executed and delivered either in person or by its duly authorized agent.

 

	Dated:	 	 	Beneficial Owner:   	 
	 	 	 	 
	 	 	 	
By:

	
 

	 	 	 	 	
Name:

	 	 	 	 	
Title:

 

PLEASE FAX A COPY OF THE COMPLETED AND EXECUTED NOTICE AND QUESTIONNAIRE, AND RETURN THE ORIGINAL BY OVERNIGHT MAIL, TO:

 

 

	 	
McKenna Long & Aldridge LLP

303 Peachtree Street, NE

Suite 5300

Atlanta, GA  30308

Attn:  Thomas Wardell

Facsimile:  404.527.8890

 

 

  

  

  

  

 

Annex C

 

Registration Rights Agreement

 

Investor Counterpart Signature Page

 

The undersigned, desiring to:  (i) enter into this Registration Rights Agreement, dated as of _________________, 2010 (the “Agreement”), between the undersigned, U.S. China Mining Group, Inc., a Nevada corporation (the “Company”), and the other parties thereto, in or substantially in the form furnished to the undersigned and (ii) purchase the securities of the Company appearing below, hereby agrees to purchase such securities from the Company as of the Closing and further agrees to join the Agreement as a party thereto, with all the rights and privileges appertaining thereto, and to be bound in all respects by the terms and conditions thereof.

 

IN WITNESS WHEREOF, the undersigned has executed the Agreement as of _____________________, 2010.

 

 

	 	Name and Address, Fax No. and Social Security No./EIN of Investor:
	 	
 

 

	 	
 

 

	 	
 

 

 

	 	Fax No.:  	 

 

	 	Soc. Sec. No./EIN: 	 

 

	 	If a partnership, corporation, trust or other business entity:

 

 

	 	
By:

	 
	 	 	
Name:

	 	 	
Title:

 

	 	If an individual:

 

 

 

	 	Signature	 

 

	 	Investment Amount:    	 

 

	 	Amount of Units to be Purchased:  	 

 

 

  

  

  

 

	 	ADDRESS FOR NOTICE

 

     

	 	c/o: 	 

 

	 	Street:   	 

 

	 	City/State/Zip: 	 

 

	 	Attention:   	 

 

	 	Tel:    	 

 

	 	Fax: 	 

 

                                             

	 	
DELIVERY INSTRUCTIONS

(if different from above)

 

 

	 	c/o: 	 

                                                                          

	 	Street:   	 

 

	 	City/State/Zip: 	 

 

	 	Attention:   	 

 

	 	Tel:    	 

 

	 	Fax: 	 

 

      

  

  

  

 

Schedule A

 

SCHEDULE OF INVESTORS

 

EXHIBIT A

 

SCHEDULE OF INVESTORS

 

	
Name

	
Investment 

Amount

	
Number 

of Shares

	
Number of Shares 

Subject to 

Warrants

	
TASLIMI, MEHRAN M

	
 $          700,000

	
175,000

	
87,500

	
TASLIMI, SHIDAN

	
 $          700,000

	
175,000

	
87,500

	
RAVENEL III, BRUCE WALKER

	
 $          400,000

	
100,000

	
50,000

	
DAYBREAK SPECIAL SITUATIONS MASTER FUND

	
 $          300,000

	
75,000

	
37,500

	
POTAPCHUK, RICHARD

	
 $          300,000

	
75,000

	
37,500

	
MMH GROUP LLC

	
 $          200,000

	
50,000

	
25,000

	
WELSH, KERRY LEE & HELEN

	
 $          200,000

	
50,000

	
25,000

	
GUAGLIARDO, LARRY

	
 $          200,000

	
50,000

	
25,000

	
FELDMAN, GEORGE

	
 $          180,000

	
45,000

	
22,500

	
SCHIFF, PETER D

	
 $          160,000

	
40,000

	
20,000

	
RICHARDS, ELIZABETH

	
 $          150,000

	
37,500

	
18,750

	
WEAVER, TIMOTHY M

	
 $          150,000

	
37,500

	
18,750

	
LEARY, LAWRENCE

	
 $          150,000

	
37,500

	
18,750

	
COLTRIN, JOANNE & ANDRE

	
 $          110,000

	
27,500

	
13,750

	
NASS, ROLLOVER IRA FBO KENNETH HENRY

	
 $          110,000

	
27,500

	
13,750

	
DOMINGUEZ TRUST

	
 $          110,000

	
27,500

	
13,750

	
NOBLES, VADA

	
 $          100,000

	
25,000

	
12,500

	
NEIBERG, MARY

	
 $          100,000

	
25,000

	
12,500

 

  

  

  

 

	
POM INVESTMENTS LLC

	
 $          100,000

	
25,000

	
12,500

	
HEIMANN LIVING TR, ROBERT K

	
 $          100,000

	
25,000

	
12,500

	
MCINTYRE TRUST, ROD

	
 $          100,000

	
25,000

	
12,500

	
VDHF HOLDING CO

	
 $          100,000

	
25,000

	
12,500

	
SUTER FAMILY TRUST

	
 $          100,000

	
25,000

	
12,500

	
REISNER ROLLOVER IRA, FBO JEFFREY

	
 $          100,000

	
25,000

	
12,500

	
RICE ROLLOVER IRA, FBO MARSHALL CARL

	
 $          100,000

	
25,000

	
12,500

	
LADNER ROLLOVER IRA,  FBO THOMAS AARON

	
 $          100,000

	
25,000

	
12,500

	
VAL EYE CARE MED GRP FBO STAFF

	
 $          100,000

	
25,000

	
12,500

	
KK SWOGGER ASSET MANAGEMENT

	
 $          100,000

	
25,000

	
12,500

	
FRIESEN, WALTER

	
 $          100,000

	
25,000

	
12,500

	
TAMBORELLO ROLLOVER IRA, FBO JAMES A

	
 $          100,000

	
25,000

	
12,500

	
WAHL IRA, FBO HOWARD W

	
 $          100,000

	
25,000

	
12,500

	
KIRK, PATRICK & GLORIA

	
 $          100,000

	
25,000

	
12,500

	
PARKER, RUSSELL

	
 $          100,000

	
25,000

	
12,500

	
BACOLINI, VINCE

	
 $          100,000

	
25,000

	
12,500

	
COOPER, CAROL IMBT

	
 $          100,000

	
25,000

	
12,500

	
MCPHERSON, J MARK

	
 $          100,000

	
25,000

	
12,500

	
STEFANIK REVOCABLE TRUST, AMY J

	
 $          100,000

	
25,000

	
12,500

	
DREYER JR, JAMES D

	
 $          100,000

	
25,000

	
12,500

	
DREW & RASKIN P/S PLAN

	
 $             80,000

	
20,000

	
10,000

	
BRADBURY IRRVOC TR, JOSH D

	
 $             80,000

	
20,000

	
10,000

 

  

  

  

 

	
BRADBURY JR IRREV TRUST, JOSH D

	
 $             80,000

	
20,000

	
10,000

	
BRADBURY REVOCABLE TRUST

	
 $             80,000

	
20,000

	
10,000

	
BACON TRUST, JAMES V

	
 $             80,000

	
20,000

	
10,000

	
BROWN SEP IRA,  FBO JAMES CURTIS

	
 $             80,000

	
20,000

	
10,000

	
CREWS SEP IRA, FBO TERRY ALAN

	
 $             80,000

	
20,000

	
10,000

	
MEISTER NON-EXEMPT MARITAL TR

	
 $             80,000

	
20,000

	
10,000

	
MATULA FAMILY LP CLASS 2 A PARTNERSHIP

	
 $             80,000

	
20,000

	
10,000

	
LUNDBERG ROLLOVER IRA, FBO GERSHOM

	
 $             80,000

	
20,000

	
10,000

	
JACKSON IRA, FBO ROYCE V

	
 $             75,000

	
18,750

	
9,375

	
CATHRO TRUST, ROBERT E

	
 $             75,000

	
18,750

	
9,375

	
HANNON, TODD A & MICHELLE L

	
 $             72,000

	
18,000

	
9,000

	
FRANKLIN FAMILY TRUST, BRUCE A

	
 $             70,000

	
17,500

	
8,750

	
EVERETT, BLAKE & LISA

	
 $             70,000

	
17,500

	
8,750

	
SCULLY, MICHAEL

	
 $             70,000

	
17,500

	
8,750

	
SIMONS, EDGAR

	
 $             70,000

	
17,500

	
8,750

	
ZINK ROLLOVER IRA,  FBO PAUL HARPER

	
 $             60,000

	
15,000

	
7,500

	
LUTTER ROTH IRA, FBO JAMES ALLEN

	
 $             60,000

	
15,000

	
7,500

	
ADVANCED DERMATOLOGY ASSOC 401K

	
 $             60,000

	
15,000

	
7,500

	
KASSIN, MARC

	
 $             60,000

	
15,000

	
7,500

	
GALUZ JT LIVING TST, ALEXANDER & YANA

	
 $             60,000

	
15,000

	
7,500

 

  

  

  

 

	
MAY, FRANCIS BRENT & JONEITA JEAN

	
 $             58,000

	
14,500

	
7,250

	
BUKAMIER FAMILY TRUST

	
 $             50,000

	
12,500

	
6,250

	
DRELICK IRA,  FBO STANLEY J

	
 $             50,000

	
12,500

	
6,250

	
CLAUSSEN TRUST

	
 $             50,000

	
12,500

	
6,250

	
JOHNSON REV TRST, DOUGLAS WILLIAM

	
 $             50,000

	
12,500

	
6,250

	
FINEGOLD REVOCABL, JACK & TAMI

	
 $             50,000

	
12,500

	
6,250

	
MUNRO, PAMELA HARRINGTON

	
 $             50,000

	
12,500

	
6,250

	
MULLEN SEPERATE PRPRTY TR, PATRICK

	
 $             50,000

	
12,500

	
6,250

	
POINT AUX CHENES LLC

	
 $             50,000

	
12,500

	
6,250

	
BRABENAC, CHARLES

	
 $             50,000

	
12,500

	
6,250

	
SHEAHAN, JAMES A & MELODY K

	
 $             50,000

	
12,500

	
6,250

	
ARCHIBALD, JEFF

	
 $             50,000

	
12,500

	
6,250

	
MARK R MITCHELL MD A MEDICAL CORP DBPP

	
 $             50,000

	
12,500

	
6,250

	
AMERMAN, MATTHEW C  CARRIE

	
 $             50,000

	
12,500

	
6,250

	
PETERSON, TINA C & HENDRIKUS M SCHRAVEN

	
 $             50,000

	
12,500

	
6,250

	
EARL, BENJAMIN R & JONEE D

	
 $             50,000

	
12,500

	
6,250

	
LONG, CAROLYN R

	
 $             50,000

	
12,500

	
6,250

	
SULLIVAN, CHARLES & CAROL

	
 $             50,000

	
12,500

	
6,250

	
CLEARPATH LLC

	
 $             50,000

	
12,500

	
6,250

	
WARD, CLIFF

	
 $             50,000

	
12,500

	
6,250

	
MCNAMEE, COREY SHANNON

	
 $             50,000

	
12,500

	
6,250

 

  

  

  

 

	
CLARK JR, DONALD GIRARD & DEBRA L

	
 $             50,000

	
12,500

	
6,250

	
SCHAIRER JR, HENRY LOUIS

	
 $             50,000

	
12,500

	
6,250

	
EDWARDS, JONATHAN & VIRGINIA C ADAMS

	
 $             50,000

	
12,500

	
6,250

	
MCCARTHY, JOSEPH & MIKI

	
 $             50,000

	
12,500

	
6,250

	
SCOTT, KENT & LAURA

	
 $             50,000

	
12,500

	
6,250

	
O'NEILL, KEVIN P & SUZANNE ODELL

	
 $             50,000

	
12,500

	
6,250

	
MCHUGH, LAURA D

	
 $             50,000

	
12,500

	
6,250

	
LARSON FAMILY 2006 TRUST

	
 $             50,000

	
12,500

	
6,250

	
ALLSTATES DRYWALL INC EE S T

	
 $             50,000

	
12,500

	
6,250

	
MARTIN, MITCHELL & DEBORAH

	
 $             50,000

	
12,500

	
6,250

	
MONA ROLLOVER IRA, FBO GERALD

	
 $             50,000

	
12,500

	
6,250

	
TUMKO, OLEKSANDR & OKSANA

	
 $             50,000

	
12,500

	
6,250

	
DIPAOLO WORTHINGTON FAMILY TRUST

	
 $             50,000

	
12,500

	
6,250

	
SPADY, ROBERT NEAL & LINDA

	
 $             50,000

	
12,500

	
6,250

	
BASLER LIVING TRUST, SARAH J

	
 $             50,000

	
12,500

	
6,250

	
OLSON FAMILY TRUST

	
 $             50,000

	
12,500

	
6,250

	
CRANE TRUST, TIMOTHY R

	
 $             50,000

	
12,500

	
6,250

	
BRADLEY ANESTHESIOLOGY PSP

	
 $             50,000

	
12,500

	
6,250

	
KLEPPEN, ART & KIMBERLY

	
 $             50,000

	
12,500

	
6,250

	
BROWNE IRA,  FBO PAT

	
 $             50,000

	
12,500

	
6,250

	
WALKER ROLLOVER IRA,  FBO RUSSELL B

	
 $             50,000

	
12,500

	
6,250

	
GROFF LIVING TRUST

	
 $             50,000

	
12,500

	
6,250

 

  

  

  

 

	
YANO LOVING TRUST

	
 $             50,000

	
12,500

	
6,250

	
LARSON, DAVID W & JENNIFER L

	
 $             50,000

	
12,500

	
6,250

	
SPIELMAN AND ELKIN REV TR

	
 $             50,000

	
12,500

	
6,250

	
BARNEY REV TR, GERALD AND BEVERLY

	
 $             50,000

	
12,500

	
6,250

	
BRUNZLICK MEDICAL SERVICES INC

	
 $             50,000

	
12,500

	
6,250

	
HUNTSINGER IRA, BDA NSPS BERT JUDE

	
 $             50,000

	
12,500

	
6,250

	
SPOLUM IRA, FBO DIANE D

	
 $             50,000

	
12,500

	
6,250

	
MIGAS IRA, FBO MARYANN

	
 $             50,000

	
12,500

	
6,250

	
EDSON ROLLOVER IRA, FBO RALPH DALE

	
 $             50,000

	
12,500

	
6,250

	
HARMS ROLLOVER IRA, FBO STEVEN PAUL

	
 $             50,000

	
12,500

	
6,250

	
MADARAZ IRA, FBO GEORGE

	
 $             50,000

	
12,500

	
6,250

	
FOSS REV TR, ROBERT T & MARGARET

	
 $             50,000

	
12,500

	
6,250

	
MACCABEE TRUST

	
 $             50,000

	
12,500

	
6,250

	
CYR, WILLIAM J

	
 $             50,000

	
12,500

	
6,250

	
BUCKTHORN LLC

	
 $             50,000

	
12,500

	
6,250

	
BENSON LIVING TRUST, NANCY L

	
 $             50,000

	
12,500

	
6,250

	
SANDERS FAM TR REV TR, GAYLE M & DEBORAH

	
 $             50,000

	
12,500

	
6,250

	
KINZUA INVESTMENT CLUB

	
 $             50,000

	
12,500

	
6,250

	
GLASER JR ROLLOVER IRA, FBO DONALD T

	
 $             50,000

	
12,500

	
6,250

	
 SCULLY, DAVID ALAN

	
 $             50,000

	
12,500

	
6,250

	
NASS, IRA FBO TIMOTHY

	
 $             50,000

	
12,500

	
6,250

 

  

  

  

 

	
FOREMAN TRUST, DEBORAH D

	
 $             50,000

	
12,500

	
6,250

	
FRED HARPER LLC

	
 $             50,000

	
12,500

	
6,250

	
HEINKING, MARY

	
 $             50,000

	
12,500

	
6,250

	
DUNKUM III IRA,  FBO WILLIS

	
 $             50,000

	
12,500

	
6,250

	
KESSLER, CYNTHIA & JAMES

	
 $             50,000

	
12,500

	
6,250

	
MOHR TRUST, EDWARD CHARLES

	
 $             50,000

	
12,500

	
6,250

	
QMI FERTILIZER & GRAIN INC

	
 $             50,000

	
12,500

	
6,250

	
BISHOP, ROBERT L  TOD FRANCINE

	
 $             50,000

	
12,500

	
6,250

	
ELLIS IRA - BDA NSPS BARBARA

	
 $             50,000

	
12,500

	
6,250

	
NAHUM, ANTHONY

	
 $             50,000

	
12,500

	
6,250

	
SORGE JR IRA, FBO PAUL E

	
 $             50,000

	
12,500

	
6,250

	
KARAMAOUN, NICOLAS

	
 $             50,000

	
12,500

	
6,250

	
SCHEIN VENTURES LLC

	
 $             50,000

	
12,500

	
6,250

	
ROZOV, YADIN

	
 $             50,000

	
12,500

	
6,250

	
HEARST, BARBARA

	
 $             50,000

	
12,500

	
6,250

	
LEWIS DECL OF TRUST, CINDY J

	
 $             50,000

	
12,500

	
6,250

	
CARDILE SR, FRANK

	
 $             50,000

	
12,500

	
6,250

	
GARY MARDER DO TR ALLERGY DERMATOLOGY & SKIN INC

	
 $             50,000

	
12,500

	
6,250

	
GRIFFIN UTMA OH, DANIEL J

	
 $             50,000

	
12,500

	
6,250

	
GRIFFIN UTMA OH, MICHELLE E

	
 $             50,000

	
12,500

	
6,250

	
GRIFFIN, JULIA L

	
 $             50,000

	
12,500

	
6,250

	
SCHWARTZ, MIRIAM

	
 $             50,000

	
12,500

	
6,250

	
MUELLER, SCOTT

	
 $             50,000

	
12,500

	
6,250

	
GRIFFIN, SCOTT R

	
 $             50,000

	
12,500

	
6,250

 

  

  

  

 

	
SMITH, STEVE

	
 $             50,000

	
12,500

	
6,250

	
KLOECKNER, DARREL LEE

	
 $             50,000

	
12,500

	
6,250

	
STEPHEN P MCCARRON P C PFT SHRING PL

	
 $             50,000

	
12,500

	
6,250

	
RAWLINGS, JASON L & LEANNE K

	
 $             50,000

	
12,500

	
6,250

	
HSIAO, CHIN

	
 $             50,000

	
12,500

	
6,250

	
FRIED FAMILY TRUST

	
 $             50,000

	
12,500

	
6,250

	
THIARA FAMILY TRUST

	
 $             50,000

	
12,500

	
6,250

	
BELASCO, CHARLOTTE J

	
 $             50,000

	
12,500

	
6,250

	
KERENYI, JUSTIN

	
 $             50,000

	
12,500

	
6,250

	
OSTERHAUS REV TR, MARK A

	
 $             50,000

	
12,500

	
6,250

	
SCHORTMANN, PETER & SUSAN

	
 $             50,000

	
12,500

	
6,250

	
ANTHONY III, RICHARD P & KIMBERLY J

	
 $             50,000

	
12,500

	
6,250

	
GHAI, VIVEK

	
 $             50,000

	
12,500

	
6,250

	
KIENE, HEIDI W & KEVIN

	
 $             40,000

	
10,000

	
5,000

	
SCOTT R LENNES IRA LLC

	
 $             40,000

	
10,000

	
5,000

	
WILEY FAMILY LIVING TRUST

	
 $             40,000

	
10,000

	
5,000

	
MOORE, RICHARD

	
 $             40,000

	
10,000

	
5,000

	
CARROLL, TIMOTHY

	
 $             40,000

	
10,000

	
5,000

	
KEALY REVOCABLE TRUST, JOHN T

	
 $             40,000

	
10,000

	
5,000

	
GLEASON, KENNETH RAY

	
 $             40,000

	
10,000

	
5,000

	
GLEASON, RANDELL SCOTT & MICHELE LEE

	
 $             40,000

	
10,000

	
5,000

	
BIZ, TONY &  JEANNE C LIM

	
 $             40,000

	
10,000

	
5,000

 

  

  

  

 

	
BEESON, CURTIS ANDREW & BRENDA BATENBURG

	
 $             40,000

	
10,000

	
5,000

	
ABRAMS PENSION PLAN 1, JACK

	
 $             40,000

	
10,000

	
5,000

	
GADOL DMD PSP

	
 $             40,000

	
10,000

	
5,000

	
SURERUS IRA, FBO GERARD

	
 $             40,000

	
10,000

	
5,000

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00183-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00183-of-00352.parquet"}]]